Track market-moving stories before they get noisy

Posted by Defense World Staff on Jul 22nd, 2026

Fifth Third Bancorp lifted its holdings in shares of Albertsons Companies, Inc. (NYSE:ACI – Free Report) by 2,707.5% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 123,867 shares of the company’s stock after purchasing an additional 119,455 shares during the quarter. Fifth Third Bancorp’s holdings in Albertsons Companies were worth $2,111,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. CWM LLC increased its position in shares of Albertsons Companies by 103.5% during the fourth quarter. CWM LLC now owns 1,435 shares of the company’s stock valued at $25,000 after acquiring an additional 730 shares during the last quarter. MassMutual Private Wealth & Trust FSB raised its stake in shares of Albertsons Companies by 185.1% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,628 shares of the company’s stock valued at $28,000 after acquiring an additional 1,057 shares during the period. NBC Securities Inc. lifted its holdings in shares of Albertsons Companies by 91.2% in the 4th quarter. NBC Securities Inc. now owns 1,855 shares of the company’s stock worth $32,000 after acquiring an additional 885 shares during the last quarter. EverSource Wealth Advisors LLC lifted its holdings in shares of Albertsons Companies by 172.8% in the 4th quarter. EverSource Wealth Advisors LLC now owns 2,062 shares of the company’s stock worth $35,000 after acquiring an additional 1,306 shares during the last quarter. Finally, Elevation Wealth Partners LLC purchased a new position in shares of Albertsons Companies during the 4th quarter worth approximately $46,000. 71.35% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In Several analysts recently weighed in on the stock. Wells Fargo & Company dropped their target price on shares of Albertsons Companies from $21.00 to $18.00 and set an “overweight” rating for the company in a report on Monday, June 29th. Citigroup lowered their price target on Albertsons Companies from $22.00 to $17.00 and set a “buy” rating for the company in a research report on Monday, June 29th. UBS Group dropped their price objective on Albertsons Companies from $23.00 to $20.00 and set a “buy” rating for the company in a research note on Wednesday, April 15th. Weiss Ratings downgraded Albertsons Companies from a “hold (c-)” rating to a “sell (d+)” rating in a report on Friday, May 29th. Finally, Royal Bank Of Canada reiterated an “outperform” rating and issued a $21.00 price objective on shares of Albertsons Companies in a report on Monday, April 6th. Nine analysts have rated the stock with a Buy rating, four have given a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $20.25.

Get Our Latest Stock Report on ACI

Albertsons Companies Trading Down 1.7% Shares of ACI stock opened at $14.70 on Wednesday. Albertsons Companies, Inc. has a fifty-two week low of $13.16 and a fifty-two week high of $20.91. The company has a 50 day moving average price of $15.08 and a 200 day moving average price of $16.45. The stock has a market capitalization of $7.20 billion, a P/E ratio of 45.94, a price-to-earnings-growth ratio of 1.71 and a beta of 0.42. The company has a debt-to-equity ratio of 4.58, a quick ratio of 0.20 and a current ratio of 0.86.

Albertsons Companies Dividend Announcement The firm also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Friday, July 24th will be paid a $0.17 dividend. The ex-dividend date is Friday, July 24th. This represents a $0.68 annualized dividend and a dividend yield of 4.6%. Albertsons Companies’s payout ratio is 212.50%.

Albertsons Companies Profile (Free Report)

Albertsons Companies, Inc (NYSE: ACI) is one of the largest food and drug retailers in the United States, operating a diversified portfolio of grocery store banners. Founded in 1939 by Joe Albertson in Boise, Idaho, the company has grown through both organic expansion and strategic acquisitions. Its core business activities encompass the sale of fresh produce, meat, bakery items, deli offerings, pharmacy services, and general merchandise. The company’s retail operations are complemented by an in-house private-label program, featuring brands such as O Organics, Open Nature, and Lucerne, which cater to a range of customer preferences and price points.

Throughout its history, Albertsons Companies has pursued growth via mergers and partnerships.

Featured Articles Five stocks we like better than Albertsons Companies Confidence Is Back, But Earnings Show the Consumer Is Being Picky AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative? 3 Photonics Companies Making Quantum Tech Possible

Receive News & Ratings for Albertsons Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albertsons Companies and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAcumen Wealth Advisors LLC Decreases Stock Position in UnitedHealth Group Incorporated $UNH

NEXT HEADLINE »ABN Amro Investment Solutions Decreases Stock Position in Quanta Services, Inc. $PWR

Posted by Defense World Staff on Jul 22nd, 2026

California Public Employees Retirement System lowered its position in Pinnacle West Capital Corporation (NYSE:PNW – Free Report) by 13.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 275,327 shares of the utilities provider’s stock after selling 41,749 shares during the period. California Public Employees Retirement System owned about 0.23% of Pinnacle West Capital worth $27,739,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Kera Capital Partners Inc. lifted its holdings in Pinnacle West Capital by 13.4% in the first quarter. Kera Capital Partners Inc. now owns 4,535 shares of the utilities provider’s stock valued at $457,000 after acquiring an additional 537 shares during the period. Assetmark Inc. grew its stake in shares of Pinnacle West Capital by 32.8% during the 1st quarter. Assetmark Inc. now owns 1,719 shares of the utilities provider’s stock valued at $173,000 after purchasing an additional 425 shares during the period. NovaPoint Capital LLC grew its stake in shares of Pinnacle West Capital by 9.8% during the 1st quarter. NovaPoint Capital LLC now owns 13,741 shares of the utilities provider’s stock valued at $1,384,000 after purchasing an additional 1,222 shares during the period. Bessemer Group Inc. increased its position in shares of Pinnacle West Capital by 26.1% during the 1st quarter. Bessemer Group Inc. now owns 4,934 shares of the utilities provider’s stock valued at $496,000 after purchasing an additional 1,020 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC increased its position in shares of Pinnacle West Capital by 1,510.9% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 115,939 shares of the utilities provider’s stock valued at $11,771,000 after purchasing an additional 108,742 shares during the last quarter. Hedge funds and other institutional investors own 91.51% of the company’s stock.

Pinnacle West Capital Stock Down 0.7% NYSE PNW opened at $105.61 on Wednesday. The stock’s 50-day moving average price is $104.01 and its 200-day moving average price is $100.19. The company has a quick ratio of 0.39, a current ratio of 0.60 and a debt-to-equity ratio of 1.38. Pinnacle West Capital Corporation has a 52 week low of $85.32 and a 52 week high of $111.16. The company has a market capitalization of $12.80 billion, a P/E ratio of 19.67, a price-to-earnings-growth ratio of 3.87 and a beta of 0.43.

Pinnacle West Capital (NYSE:PNW – Get Free Report) last posted its quarterly earnings data on Monday, May 4th. The utilities provider reported $0.27 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.03) by $0.30. The firm had revenue of $1.15 billion for the quarter, compared to analysts’ expectations of $1.08 billion. Pinnacle West Capital had a return on equity of 9.27% and a net margin of 11.99%.The business’s quarterly revenue was up 11.4% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.04) EPS. Pinnacle West Capital has set its FY 2026 guidance at 4.550-4.750 EPS. On average, equities research analysts predict that Pinnacle West Capital Corporation will post 4.73 earnings per share for the current year.

Pinnacle West Capital Announces Dividend The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 1st. Shareholders of record on Monday, August 3rd will be given a $0.91 dividend. This represents a $3.64 dividend on an annualized basis and a dividend yield of 3.4%. The ex-dividend date is Monday, August 3rd. Pinnacle West Capital’s dividend payout ratio is presently 67.78%.

Insider Buying and Selling at Pinnacle West Capital In other news, EVP Jacob Tetlow sold 6,567 shares of the stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $99.00, for a total value of $650,133.00. Following the completion of the sale, the executive vice president directly owned 6,634 shares of the company’s stock, valued at $656,766. This represents a 49.75% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.19% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In Several brokerages have recently weighed in on PNW. Jefferies Financial Group reiterated a “buy” rating and issued a $129.00 price objective on shares of Pinnacle West Capital in a research note on Wednesday, July 8th. Argus boosted their target price on shares of Pinnacle West Capital from $95.00 to $106.00 and gave the company a “buy” rating in a research report on Tuesday, April 14th. Wells Fargo & Company set a $106.00 target price on shares of Pinnacle West Capital in a report on Tuesday, April 21st. TD Cowen increased their price target on shares of Pinnacle West Capital from $100.00 to $101.00 and gave the stock a “hold” rating in a research report on Friday, May 15th. Finally, Truist Financial dropped their price target on shares of Pinnacle West Capital from $108.00 to $105.00 and set a “hold” rating on the stock in a research note on Friday, May 29th. Three research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $104.14.

Get Our Latest Stock Report on PNW

Pinnacle West Capital Profile (Free Report)

Pinnacle West Capital Corporation is a publicly traded utility holding company headquartered in Phoenix, Arizona. Through its principal subsidiary, Arizona Public Service Company (APS), Pinnacle West generates, transmits and distributes electricity to more than one million residential, commercial and industrial customers across central and southern Arizona. The company’s regulated operations focus on delivering safe, reliable power while meeting evolving environmental standards.

The company’s diversified generation portfolio includes natural gas–fired plants, the nuclear-powered Palo Verde Generating Station—the largest nuclear facility in the United States by net output—plus growing investments in solar and battery storage projects.

Featured Articles Five stocks we like better than Pinnacle West Capital Confidence Is Back, But Earnings Show the Consumer Is Being Picky AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative? 3 Photonics Companies Making Quantum Tech Possible

Receive News & Ratings for Pinnacle West Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pinnacle West Capital and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEDimensional Fund Advisors LP Raises Stock Holdings in PayPal Holdings, Inc. $PYPL

NEXT HEADLINE »California Public Employees Retirement System Sells 56,857 Shares of Equifax, Inc. $EFX

Posted by Defense World Staff on Jul 22nd, 2026

Andra AP fonden lifted its position in shares of Insmed, Inc. (NASDAQ:INSM – Free Report) by 114.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 77,970 shares of the biopharmaceutical company’s stock after acquiring an additional 41,670 shares during the period. Andra AP fonden’s holdings in Insmed were worth $12,750,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also bought and sold shares of the company. EverSource Wealth Advisors LLC boosted its stake in shares of Insmed by 65.6% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 664 shares of the biopharmaceutical company’s stock valued at $67,000 after purchasing an additional 263 shares in the last quarter. First Trust Advisors LP boosted its holdings in shares of Insmed by 80.8% during the 2nd quarter. First Trust Advisors LP now owns 47,392 shares of the biopharmaceutical company’s stock valued at $4,770,000 after acquiring an additional 21,176 shares in the last quarter. Baird Financial Group Inc. bought a new stake in Insmed during the 2nd quarter worth $2,589,000. Amundi increased its holdings in Insmed by 21,194.4% in the 2nd quarter. Amundi now owns 11,499 shares of the biopharmaceutical company’s stock worth $1,130,000 after purchasing an additional 11,445 shares in the last quarter. Finally, Natixis acquired a new position in Insmed in the 2nd quarter worth about $1,072,000.

Wall Street Analyst Weigh In A number of brokerages have recently commented on INSM. Morgan Stanley raised Insmed from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $166.00 to $212.00 in a research note on Monday, March 30th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Insmed in a research note on Friday. Wells Fargo & Company raised their price objective on shares of Insmed from $160.00 to $161.00 and gave the company an “overweight” rating in a report on Wednesday, July 15th. Royal Bank Of Canada cut their target price on shares of Insmed from $205.00 to $195.00 and set an “outperform” rating on the stock in a research report on Friday, June 5th. Finally, Guggenheim restated a “buy” rating and issued a $207.00 price target on shares of Insmed in a research report on Friday, July 10th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-four have issued a Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $209.13.

Get Our Latest Research Report on INSM

Insmed Stock Up 1.5% Shares of NASDAQ INSM opened at $108.62 on Wednesday. The company’s 50 day moving average price is $105.64 and its 200-day moving average price is $134.69. The company has a debt-to-equity ratio of 0.80, a quick ratio of 4.10 and a current ratio of 4.47. Insmed, Inc. has a 52-week low of $90.39 and a 52-week high of $212.75. The company has a market capitalization of $23.54 billion, a P/E ratio of -18.89 and a beta of 0.78.

Insmed (NASDAQ:INSM – Get Free Report) last posted its quarterly earnings data on Thursday, May 7th. The biopharmaceutical company reported ($0.76) earnings per share for the quarter, topping the consensus estimate of ($0.90) by $0.14. Insmed had a negative net margin of 144.44% and a negative return on equity of 130.11%. The company had revenue of $305.96 million during the quarter, compared to analysts’ expectations of $300.81 million. During the same period in the prior year, the company posted ($1.42) earnings per share. Insmed’s revenue for the quarter was up 229.7% compared to the same quarter last year. Equities analysts forecast that Insmed, Inc. will post -2.43 earnings per share for the current year.

Insiders Place Their Bets In related news, COO Roger Adsett sold 2,370 shares of the firm’s stock in a transaction that occurred on Wednesday, June 3rd. The stock was sold at an average price of $102.27, for a total transaction of $242,379.90. Following the completion of the sale, the chief operating officer owned 98,603 shares of the company’s stock, valued at $10,084,128.81. This trade represents a 2.35% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO William Lewis sold 10,699 shares of the company’s stock in a transaction dated Thursday, July 9th. The shares were sold at an average price of $117.40, for a total transaction of $1,256,062.60. Following the transaction, the chief executive officer owned 259,058 shares in the company, valued at $30,413,409.20. This represents a 3.97% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 54,590 shares of company stock worth $5,793,738 in the last quarter. 2.10% of the stock is currently owned by company insiders.

Insmed Profile (Free Report)

Insmed Incorporated is a biopharmaceutical company focused on developing and commercializing therapies for patients with rare and serious diseases, with a particular emphasis on difficult-to-treat pulmonary infections. Headquartered in Bridgewater, New Jersey, the company concentrates its research and development efforts on targeted drug delivery technologies and novel formulations intended to improve clinical outcomes for patients who have limited treatment options.

The company’s principal marketed product is ARIKAYCE (amikacin liposome inhalation suspension), an inhaled liposomal formulation of the antibiotic amikacin that is approved by the U.S.

Further Reading Five stocks we like better than Insmed Confidence Is Back, But Earnings Show the Consumer Is Being Picky AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative? 3 Photonics Companies Making Quantum Tech Possible Want to see what other hedge funds are holding INSM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Insmed, Inc. (NASDAQ:INSM – Free Report).

Receive News & Ratings for Insmed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Insmed and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAmova Asset Management Americas Inc. Trims Stock Position in Teck Resources Ltd $TECK

NEXT HEADLINE »Microsoft Corporation $MSFT Shares Sold by Capstone Wealth Management Group LLC

Posted by Defense World Staff on Jul 22nd, 2026

ABN Amro Investment Solutions acquired a new stake in shares of Trane Technologies plc (NYSE:TT – Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 171,433 shares of the company’s stock, valued at approximately $71,443,000. Trane Technologies makes up approximately 0.9% of ABN Amro Investment Solutions’ portfolio, making the stock its 20th biggest holding. ABN Amro Investment Solutions owned about 0.08% of Trane Technologies as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Bell Investment Advisors Inc increased its position in shares of Trane Technologies by 12.2% in the 1st quarter. Bell Investment Advisors Inc now owns 203 shares of the company’s stock valued at $85,000 after acquiring an additional 22 shares during the period. Fiduciary Family Office LLC raised its stake in shares of Trane Technologies by 1.5% in the fourth quarter. Fiduciary Family Office LLC now owns 1,573 shares of the company’s stock worth $612,000 after purchasing an additional 23 shares during the last quarter. Foster Dykema Cabot & Partners LLC lifted its holdings in shares of Trane Technologies by 10.6% during the fourth quarter. Foster Dykema Cabot & Partners LLC now owns 239 shares of the company’s stock worth $93,000 after purchasing an additional 23 shares during the period. Bridges Investment Management Inc. lifted its holdings in shares of Trane Technologies by 1.6% during the fourth quarter. Bridges Investment Management Inc. now owns 1,542 shares of the company’s stock worth $600,000 after purchasing an additional 24 shares during the period. Finally, Cornerstone Planning Group LLC boosted its position in Trane Technologies by 14.5% in the first quarter. Cornerstone Planning Group LLC now owns 190 shares of the company’s stock valued at $79,000 after buying an additional 24 shares during the last quarter. 82.97% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth A number of equities analysts have issued reports on TT shares. Sanford C. Bernstein set a $555.00 price target on shares of Trane Technologies in a research report on Thursday, July 9th. BNP Paribas Exane initiated coverage on shares of Trane Technologies in a report on Tuesday, April 14th. They set an “outperform” rating and a $550.00 target price for the company. Barclays boosted their target price on shares of Trane Technologies from $507.00 to $585.00 and gave the company an “overweight” rating in a research report on Friday, May 1st. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Trane Technologies in a research report on Friday. Finally, Royal Bank Of Canada lifted their price objective on Trane Technologies from $440.00 to $501.00 and gave the company a “sector perform” rating in a research note on Friday, May 1st. Two research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Trane Technologies has an average rating of “Moderate Buy” and a consensus target price of $516.67.

Get Our Latest Analysis on TT

Insider Activity at Trane Technologies In other news, insider Donald E. Simmons sold 4,593 shares of the company’s stock in a transaction that occurred on Thursday, April 30th. The stock was sold at an average price of $500.00, for a total transaction of $2,296,500.00. Following the completion of the transaction, the insider directly owned 3,819 shares of the company’s stock, valued at $1,909,500. This represents a 54.60% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.43% of the stock is owned by company insiders.

Trane Technologies Trading Up 0.5% Shares of Trane Technologies stock opened at $470.42 on Wednesday. The firm has a 50-day simple moving average of $469.78 and a two-hundred day simple moving average of $448.47. The company has a market cap of $103.99 billion, a P/E ratio of 36.38, a price-to-earnings-growth ratio of 2.15 and a beta of 1.19. Trane Technologies plc has a fifty-two week low of $348.06 and a fifty-two week high of $505.87. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.77 and a current ratio of 1.10.

Trane Technologies (NYSE:TT – Get Free Report) last posted its earnings results on Friday, May 1st. The company reported $2.63 EPS for the quarter, beating analysts’ consensus estimates of $2.53 by $0.10. The firm had revenue of $4.97 billion for the quarter, compared to analysts’ expectations of $4.81 billion. Trane Technologies had a return on equity of 35.55% and a net margin of 13.41%.The company’s quarterly revenue was up 6.0% on a year-over-year basis. During the same period last year, the firm earned $2.45 EPS. As a group, equities analysts predict that Trane Technologies plc will post 14.89 earnings per share for the current fiscal year.

Trane Technologies Announces Dividend The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Friday, September 4th will be given a $1.05 dividend. The ex-dividend date is Friday, September 4th. This represents a $4.20 dividend on an annualized basis and a dividend yield of 0.9%. Trane Technologies’s payout ratio is 32.48%.

Trane Technologies Profile (Free Report)

Trane Technologies (NYSE: TT) is a global climate solutions company focused on heating, ventilation and air conditioning (HVAC) and transport refrigeration systems. The company develops, manufactures and sells a broad range of climate-control products under well-known brands, including commercial and residential HVAC equipment, building management systems and controls, and transport refrigeration units. Its product portfolio spans rooftop and packaged units, chillers, furnaces, air handlers, compressors, and related components designed for commercial buildings, industrial facilities, residences and transportation applications.

In addition to equipment, Trane Technologies provides lifecycle services that include installation, maintenance, parts, retrofit and aftermarket support, as well as digital and controls solutions for building performance and energy management.

Featured Stories Five stocks we like better than Trane Technologies Confidence Is Back, But Earnings Show the Consumer Is Being Picky AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative? 3 Photonics Companies Making Quantum Tech Possible

Receive News & Ratings for Trane Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trane Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEArvest Bank Trust Division Boosts Stake in CVS Health Corporation $CVS

NEXT HEADLINE »Assetmark Inc. Sells 3,573 Shares of Reddit Inc. $RDDT

Published Data Shows that the Active Ingredient, Lotilaner, in Credelio Quattro:

Kills existing black-legged tick (Ixodes scapularis) infestations faster2 than leading competitors, within just 8 hours of treatment.i Kills the lone star tick (Amblyomma americanum) within 12 hours of infestation; achieving the fastest3 initial speed of tick kill compared to the competition.ii Achieves a rapid speed of kill4 on Day 0 and on Day 28, with no statistically significant drop-off in performance at the end of the dosing period.i,ii Outlasts competitors whose speed of kill2,4 performance declined at the end of the month.i,ii , /PRNewswire/ -- When it comes to killing ticks, veterinarians and pet owners want it done fast. New data published in Parasites & Vectors, a leading peer-reviewed publication, demonstrates that Elanco Animal Health's (NYSE: ELAN) Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) kills ticks1 faster2 than leading competitors Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) and NexGard® Plus (afoxolaner, moxidectin, and pyrantel chewable tablets).i

Newly Published Data Found Credelio Quattro:

Dr. Kathryn Reif, Bailey-Goodwin Endowed Associate Professor in Parasitology at Auburn University. Faster2 Tick1 Speed of Kill: Credelio Quattro is the only product proven to significantly reduce black-legged ticks within 8 hours.i  Lotilaner, the active ingredient in Credelio Quattro also has the fastest initial tick speed of kill against the lone star tick - in just 12 hours – and sustains the advantage throughout the dosing interval.ii Outperforms the Competition: Outperforms Simparica Trio® (12 hours) and NexGard® Plus (24 hours) at the end of the dosing period (Day 28).i Consistency Over Competitors: Achieves 8-hour speed of kill1 on Day 0 and on Day 28 with no performance drop-off. Rapid kill is critical for preventing Lyme disease transmission, which typically occurs 24-48 hours after attachment.i "Speed of kill is a critical factor for veterinarians and pet owners when choosing parasite coverage because the longer a tick is attached, the more likely it is to transmit dangerous diseases, like Lyme disease, to pets," said Dr. Casey Locklear, veterinarian and leading parasiticides expert at Elanco. "These results reinforce that lotilaner, the active ingredient in Credelio Quattro, not only starts working fast but maintains its speed of kill4 against multiple species of ticks5, providing veterinarians and pet owners with the confidence that their dogs are protected from the very start of the month to the very end."

The black-legged tick is the primary vector for Borrelia burgdorferi, the bacterium responsible for Lyme disease and anaplasmosis. The study, which evaluated the speed of kill against Ixodes scapularis (black-legged tick), found that Credelio Quattro was the only product tested to achieve significant initial tick reduction2 within just 8 hours of infestation. Notably, this rapid speed of kill1 was maintained from the beginning of the month through Day 28, providing consistent protection for the entire dosing interval.i

"Ticks are on the move. They are no longer limited to the places or seasons where we have historically expected to find them," said Dr. Kathryn Reif, Bailey-Goodwin Endowed Associate Professor in Parasitology at Auburn University. "As their geographic range expands, so does the risk of tick bites and exposure to the pathogens they carry. Because tick-borne diseases can threaten the health of people, pets, and livestock, raising public awareness is more important than ever as tick populations grow and spread into new regions."

The findings are based on evaluation time points at 4, 8, 12, 24, and 48 hours post-treatment and reinfestation. The data demonstrates that Credelio Quattro outperforms Simparica Trio and NexGard Plus in rapid tick1 reduction, particularly in the critical first 8 to 12 hours.i

Speed of kill against Ixodes scapularis (black-legged tick)^ i

Time point at which active achieved consistent superior efficacy vs. untreated control group¥ 

Day of Study 

Credelio Quattro

(lotilaner, moxidectin, praziquantel, and pyrantel)

Simparica Trio

(sarolaner, moxidectin and pyrantel)

NexGard Plus

(afoxolaner, moxidectin, and pyrantel)

0

8 hrs 

12 hrs 

12 hrs 

21

8 hrs 

24 hrs 

24 hrs 

28

8 hrs 

12 hrs 

24 hrs 

^Tick counts were evaluated at all 4-, 8-, 12-, 24-, and 48-hour time points as part of the study design 

¥P<0.05. 

Credelio Quattro also has a U.S. Food and Drug Administration approved claim for prevention of Lyme disease in dogs as a direct result of killing black-legged ticks.

Does Credelio Quattro Kill the Lone Star Tick?

Credelio Quattro is approved to protect dogs from the lone star tick (Amblyomma americanum), and its active ingredient, lotilaner, also has the fastest3 initial speed of tick kill against the lone star tick – in just 12 hours – and sustains that advantage throughout the dosing interval.ii This aggressive and expanding tick species – established across the South, Midwest and Northeast, and continuing to spread –  is one of the hardest to kill and is best known for its association with alpha-gal syndrome, or the red meat allergy in humans. It can also transmit dangerous disease-causing pathogens to dogs.iii A 2024 head-to-head study published in Parasites & Vectors compared lotilaner, the active ingredient in Credelio (lotilaner) and Credelio Quattro with sarolaner in Simparica Trio and afoxolaner in NexGard®, and found that lotilaner kills the lone star tick faster4 than sarolaner in Simparica Trio and afoxolaner in NexGard, protecting dogs against this pathogen-carrying tick.  

Speed of kill against Amblyomma americanum (lone star tick)^ ii

Time point at which active achieved consistent superior efficacy vs. untreated control group¥ 

Day of Study

Credelio

(lotilaner)

Sarolaner

(sarolaner, moxidectin and pyrantel)

NexGard

(afoxolaner)

0

12 hrs

24 hrs

24 hrs

21

12 hrs

48 hrs

48 hrs

28

8 hrs

48 hrs

72 hrs

^Tick counts were evaluated at all 4-, 8-, 12-, 24-, 48-, and 72-hour time points as part of the study design 

¥P<0.05. 

"With a heavier tick season and emergency room visits from tick bites on the riseiv, pet owners should remain vigilant and keep their pets on year-round parasite coverage," Dr. Locklear notes. "We continue to look for opportunities to make parasite protection stronger and evolve research around best-in-class medicines."

Frequently Asked Questions About Ticks and Credelio Quattro:

How fast does Credelio Quattro kill ticks? 

Studies show that lotilaner, the active ingredient in Credelio Quattro kills ticks5  faster6 than the competition.i,ii A 2026 study published in Parasites & Vectors shows that Credelio Quattro achieved significant reduction2 of black-legged ticks within 8 hours of infestation.i A 2024 study shows that lotilaner, the active ingredient in Credelio and Credelio Quattro also has the fastest3 initial speed of tick kill against the lone star tick – in just 12 hours – and sustains that advantage throughout the dosing interval.ii

Why is it important to kill ticks quickly?

The risk of disease transmission increases the longer a tick remains attached, making rapid speed of kill a critical factor in preventing the transmission of disease. A 2026 study shows that Credelio Quattro was the only product tested that significantly reduced2 black-legged ticks within 8 hours.i

Does Credelio Quattro lose effectiveness to kill ticks1 quickly at the end of the month? 

No. The data shows that Credelio Quattro maintains its 8-hour speed of kill2 on Day 28, whereas competitors showed a decline in performance.i

Are black-legged ticks linked to the red meat allergy in humans?

In the United States, alpha-gal syndrome, or red meat allergy, is usually associated with bites from the lone star tick (Amblyomma americanum); however, two Emerging Infectious Diseases studies link bites from black-legged ticks (deer ticks) and western black-legged ticks to potentially life-threatening alpha-gal syndrome.v Additional work will be needed to determine a possible link, according to the researchers, but this continues to put emphasis on the need for tick bite protection for humans.

To learn more about Credelio Quattro visit CredelioQuattroVet.com.

PM-US-26-1188

Ixodes scapularis (black-legged tick) Based on the time to statistical significance vs. control in a head-to-head study on Day 0 post-treatment and Day 28 for reinfestations comparing Credelio Quattro, which contains lotilaner as well as moxidectin, praziquantel, and pyrantel—to the active ingredients in Simparica Trio (sarolaner, moxidectin, and pyrantel) and NexGard Plus (afoxolaner, moxidectin, and pyrantel) against Ixodes scapularis. Based on the time to statistical significance vs. control in a head-to-head study comparing Credelio (lotilaner)—not Credelio Quattro, which contains lotilaner as well as moxidectin, praziquantel, and pyrantel—to the active ingredients in Simparica Trio (sarolaner, moxidectin, and pyrantel) and NexGard (afoxolaner).  Based on the time to statistical significance vs control in two separate head-to-head studies. The first study compared Credelio (lotilaner)—not Credelio Quattro, which contains lotilaner as well as moxidectin, praziquantel, and pyrantel—to the active ingredients in Simparica Trio (sarolaner, moxidectin, and pyrantel) and NexGard (afoxolaner) against Amblyomma americanum. The second study compared Credelio Quattro, which contains lotilaner as well as moxidectin, praziquantel, and pyrantel—to the active ingredients in Simparica Trio (sarolaner, moxidectin, and pyrantel) and NexGard Plus (afoxolaner, moxidectin, and pyrantel) against I. scapularis. Ixodes scapularis (black-legged tick) and Amblyomma americanum (lone star tick) NexGard and NexGard Plus are registered trademarks of Boehringer Ingelheim Animal Health USA Inc. Simparica Trio is a registered trademark of Zoetis Services LLC.

Credelio Quattro, Credelio, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. Other company and product names are trademarks of their respective owners. © 2026 Elanco or its affiliates

ABOUT ELANCO
Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders and society as a whole. With 70 years of animal health heritage, we are committed to breaking boundaries and going beyond to help our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our purpose – all to Go Beyond for Animals, Customers, Society and Our People. Learn more at www.elanco.com.

Indications for Credelio Quattro/Credelio Quattro-CA1

Credelio Quattro is indicated for the prevention of heartworm disease and the treatment and control of roundworm, hookworm, and tapeworm infections. Credelio Quattro kills adult fleas and is indicated for the treatment and prevention of flea infestations and the treatment and control of tick infestations for 1 month in dogs and puppies 8 weeks of age and older and weighing 3.3 pounds or greater. Credelio Quattro is indicated for the prevention of Lyme disease infections as a direct result of killing black-legged ticks.

Credelio Quattro-CA1 is conditionally approved for the treatment of infestations caused by New World screwworm (NWS) larvae in dogs and puppies 8 weeks of age and older and weighing 3.3 pounds or greater.

Important Safety Information for Credelio Quattro/Credelio Quattro-CA1

Lotilaner, an ingredient in Credelio Quattro/Credelio Quattro-CA1, belongs to the isoxazoline class and has been associated with neurologic adverse reactions like tremors, incoordination, and seizures even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. Dogs should be tested for existing heartworm infections before Credelio Quattro/Credelio Quattro-CA1 administration as it is not effective against adult heartworms. The safe use in breeding, pregnant, or lactating dogs has not been evaluated. The most frequently reported adverse reactions in clinical trials were vomiting and diarrhea.

Credelio Quattro-CA1 is conditionally approved by the FDA pending a full demonstration of effectiveness under application number 141-619. If you suspect that your dog is infested with NWS larvae, seek veterinary care immediately for treatment to include removal of larvae and appropriate wound care.

For complete safety information, please see the Credelio Quattro/Credelio Quattro-CA1 product label or ask your veterinarian.

Indications for Credelio
Credelio kills adult fleas and is indicated for the treatment and prevention of flea infestations and treatment and control of tick infestations (lone star tick, American dog tick, black-legged tick, brown dog tick, and longhorned tick) for one month in dogs and puppies 8 weeks and older and 4.4 pounds or greater. Credelio is indicated for the prevention of Lyme disease infections as a direct result of killing black-legged ticks.

Important Safety Information for Credelio
Lotilaner is a member of the isoxazoline class of drugs. This class has been associated with neurologic adverse reactions including tremors, incoordination, and seizures. Seizures have been reported in dogs receiving this class of drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. The safe use of Credelio in breeding, pregnant or lactating dogs has not been evaluated. The most frequently reported adverse reactions are weight loss, elevated blood urea nitrogen, increased urination, and diarrhea. For complete safety information, please see Credelio product label or ask your veterinarian.

i Reif, K.E., Kollasch, T.M., Locklear, C.L. et al. Comparative speed of kill of induced Ixodes scapularis infestations following treatment of dogs with endectocides containing either sarolaner (Simparica Trio™), afoxolaner (NexGard® PLUS), or lotilaner (Credelio Quattro™). Parasites Vectors (2026). https://doi.org/10.1186/s13071-026-07559-y
ii  Reif KE, Kollasch TM, Neilson JC, Herrin BH, Ryan WG, Bell MC, Beltz MS, Dryden MW, Jesudoss Chelladurai JRJ, Miller KR, Sutherland CJ. Comparative speed of kill provided by lotilaner (Credelio™), sarolaner (Simparica Trio™), and afoxolaner (NexGard™) to control Amblyomma americanum infestations on dogs. Parasite Vectors. 2024 Jul 20;17(1):313.
iii Centers for Disease Control and Prevention. (n.d.). Where Ticks Live. Centers for Disease Control and Prevention. Retrieved August 8, 2024, from https://www.cdc.gov/ticks/about/where-ticks-live.html
iv CDC Data Show Weekly ER Visits for Tick Bites Higher Than Usual." Centers for Disease Control and Prevention, 23 Apr. 2026,
v Van Beusekom, Mary. "Research Ties Bites from 2 More Types of Ticks to Red Meat Allergy." CIDRAP (Center for Infectious Disease Research and Policy), 4 Apr. 2025

Investor Contact: Tiffany Kanaga (765) 740-0314 [email protected]
Media Contact: Season Solorio (765) 316-0233 [email protected]

SOURCE Elanco Animal Health

Posted by Defense World Staff on Jul 22nd, 2026

California Public Employees Retirement System lifted its stake in shares of RBC Bearings Incorporated (NYSE:RBC – Free Report) by 1.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 51,856 shares of the industrial products company’s stock after acquiring an additional 944 shares during the period. California Public Employees Retirement System owned approximately 0.16% of RBC Bearings worth $28,164,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Comerica Bank boosted its position in shares of RBC Bearings by 19.5% during the fourth quarter. Comerica Bank now owns 90,283 shares of the industrial products company’s stock worth $40,486,000 after buying an additional 14,747 shares during the period. Wealth Enhancement Advisory Services LLC grew its holdings in shares of RBC Bearings by 263.5% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 3,737 shares of the industrial products company’s stock worth $1,788,000 after buying an additional 2,709 shares in the last quarter. Fifth Third Bancorp raised its position in RBC Bearings by 12,957.3% in the 1st quarter. Fifth Third Bancorp now owns 74,949 shares of the industrial products company’s stock valued at $40,707,000 after buying an additional 74,375 shares during the last quarter. M&T Bank Corp raised its position in RBC Bearings by 372.6% in the 4th quarter. M&T Bank Corp now owns 23,640 shares of the industrial products company’s stock valued at $10,601,000 after buying an additional 18,638 shares during the last quarter. Finally, Bessemer Group Inc. lifted its stake in RBC Bearings by 9.6% in the 4th quarter. Bessemer Group Inc. now owns 83,865 shares of the industrial products company’s stock valued at $37,607,000 after acquiring an additional 7,315 shares in the last quarter.

Insider Buying and Selling In other news, VP John J. Feeney sold 225 shares of RBC Bearings stock in a transaction dated Thursday, June 25th. The shares were sold at an average price of $657.94, for a total value of $148,036.50. Following the completion of the transaction, the vice president owned 2,378 shares of the company’s stock, valued at $1,564,581.32. This trade represents a 8.64% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Dolores J. Ennico sold 600 shares of RBC Bearings stock in a transaction dated Wednesday, June 24th. The shares were sold at an average price of $636.11, for a total transaction of $381,666.00. Following the completion of the transaction, the director directly owned 7,254 shares of the company’s stock, valued at approximately $4,614,341.94. This trade represents a 7.64% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 1,425 shares of company stock worth $885,400. Insiders own 1.90% of the company’s stock.

Analyst Upgrades and Downgrades A number of research firms have weighed in on RBC. Truist Financial reaffirmed a “buy” rating and set a $615.00 price target (up from $599.00) on shares of RBC Bearings in a research report on Tuesday, May 19th. Morgan Stanley boosted their price objective on shares of RBC Bearings from $600.00 to $640.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 19th. Wall Street Zen cut shares of RBC Bearings from a “buy” rating to a “hold” rating in a report on Saturday, June 27th. Zacks Research cut shares of RBC Bearings from a “strong-buy” rating to a “hold” rating in a report on Wednesday, June 3rd. Finally, Weiss Ratings raised shares of RBC Bearings from a “buy (b-)” rating to a “buy (b)” rating in a research report on Wednesday, July 15th. Six research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $584.00.

Get Our Latest Stock Analysis on RBC Bearings

RBC Bearings Stock Up 2.7% RBC stock opened at $584.13 on Wednesday. The company has a quick ratio of 0.78, a current ratio of 2.18 and a debt-to-equity ratio of 0.21. The business has a 50 day moving average price of $597.69 and a two-hundred day moving average price of $565.13. The company has a market cap of $18.48 billion, a price-to-earnings ratio of 64.26, a P/E/G ratio of 3.26 and a beta of 1.40. RBC Bearings Incorporated has a twelve month low of $364.50 and a twelve month high of $667.69.

RBC Bearings (NYSE:RBC – Get Free Report) last posted its quarterly earnings results on Friday, May 15th. The industrial products company reported $3.62 earnings per share for the quarter, topping the consensus estimate of $3.31 by $0.31. The firm had revenue of $518.00 million for the quarter, compared to analyst estimates of $505.90 million. RBC Bearings had a return on equity of 11.35% and a net margin of 15.37%.The business’s quarterly revenue was up 18.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.83 EPS. Analysts anticipate that RBC Bearings Incorporated will post 13.59 EPS for the current fiscal year.

RBC Bearings Profile (Free Report)

RBC Bearings Incorporated is a global designer, manufacturer and marketer of highly engineered precision bearings and components for extreme applications. The company’s product portfolio includes cylindrical roller bearings, spherical plain bearings, ball bearings, track rollers, and engineered components such as metal-to-metal and polymer bearings. These products are tailored to meet the demanding requirements of aerospace, defense and industrial customers where reliability under severe conditions is critical.

The company’s bearings and components find application in aircraft engines, auxiliary power units, landing gear systems, space and missile programs, industrial gas turbines, oil and gas drilling equipment, and heavy machinery.

Featured Articles Five stocks we like better than RBC Bearings Confidence Is Back, But Earnings Show the Consumer Is Being Picky AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative? 3 Photonics Companies Making Quantum Tech Possible Want to see what other hedge funds are holding RBC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RBC Bearings Incorporated (NYSE:RBC – Free Report).

Receive News & Ratings for RBC Bearings Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RBC Bearings and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEArvest Bank Trust Division Has $7.08 Million Holdings in Procter & Gamble Company (The) $PG

NEXT HEADLINE »California Public Employees Retirement System Boosts Stake in East West Bancorp, Inc. $EWBC

Posted by Defense World Staff on Jul 22nd, 2026

Andra AP fonden boosted its holdings in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 283.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 114,969 shares of the medical research company’s stock after acquiring an additional 84,969 shares during the quarter. Andra AP fonden’s holdings in Edwards Lifesciences were worth $9,207,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. MV Capital Management Inc. purchased a new stake in Edwards Lifesciences during the fourth quarter worth about $26,000. Hanson & Doremus Investment Management acquired a new position in shares of Edwards Lifesciences in the first quarter valued at approximately $25,000. Kemnay Advisory Services Inc. purchased a new stake in Edwards Lifesciences during the 4th quarter worth approximately $27,000. JPL Wealth Management LLC acquired a new stake in Edwards Lifesciences during the 3rd quarter worth approximately $25,000. Finally, Hilton Head Capital Partners LLC purchased a new position in Edwards Lifesciences in the 4th quarter valued at approximately $28,000. Hedge funds and other institutional investors own 79.46% of the company’s stock.

Edwards Lifesciences Trading Down 0.7% NYSE EW opened at $84.41 on Wednesday. The firm’s fifty day moving average price is $87.60 and its 200 day moving average price is $83.91. Edwards Lifesciences Corporation has a 12 month low of $72.30 and a 12 month high of $96.29. The company has a debt-to-equity ratio of 0.06, a current ratio of 4.42 and a quick ratio of 3.63. The company has a market capitalization of $48.61 billion, a price-to-earnings ratio of 44.90, a price-to-earnings-growth ratio of 2.13 and a beta of 0.86.

Edwards Lifesciences (NYSE:EW – Get Free Report) last issued its quarterly earnings data on Thursday, April 23rd. The medical research company reported $0.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.73 by $0.05. Edwards Lifesciences had a net margin of 17.39% and a return on equity of 15.19%. The company had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.60 billion. During the same period last year, the firm posted $0.64 EPS. Edwards Lifesciences’s revenue for the quarter was up 16.7% on a year-over-year basis. Edwards Lifesciences has set its FY 2026 guidance at 2.950-3.050 EPS and its Q2 2026 guidance at 0.700-0.760 EPS. On average, sell-side analysts expect that Edwards Lifesciences Corporation will post 3 earnings per share for the current fiscal year.

Analysts Set New Price Targets EW has been the topic of several analyst reports. TD Cowen reiterated a “buy” rating on shares of Edwards Lifesciences in a research note on Tuesday. Royal Bank Of Canada upped their target price on shares of Edwards Lifesciences from $100.00 to $110.00 and gave the stock an “outperform” rating in a research note on Monday, July 13th. BTIG Research raised their target price on shares of Edwards Lifesciences from $100.00 to $110.00 and gave the company a “buy” rating in a report on Tuesday, June 30th. Wall Street Zen downgraded shares of Edwards Lifesciences from a “buy” rating to a “hold” rating in a research note on Saturday, July 4th. Finally, Canaccord Genuity Group set a $85.00 price target on shares of Edwards Lifesciences and gave the stock a “hold” rating in a report on Friday, April 24th. Two analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat, Edwards Lifesciences presently has a consensus rating of “Moderate Buy” and an average target price of $98.95.

Get Our Latest Stock Analysis on EW

Insider Buying and Selling at Edwards Lifesciences In related news, VP Donald E. Bobo, Jr. sold 23,145 shares of the stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $86.42, for a total value of $2,000,190.90. Following the sale, the vice president directly owned 98,611 shares of the company’s stock, valued at approximately $8,521,962.62. This represents a 19.01% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Daniel J. Lippis sold 619 shares of the firm’s stock in a transaction on Friday, July 10th. The stock was sold at an average price of $91.70, for a total value of $56,762.30. Following the transaction, the vice president directly owned 40,034 shares of the company’s stock, valued at $3,671,117.80. The trade was a 1.52% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 45,577 shares of company stock valued at $3,855,527. 0.31% of the stock is owned by corporate insiders.

Edwards Lifesciences Company Profile (Free Report)

Edwards Lifesciences is a medical technology company focused on products and therapies for structural heart disease and critical care monitoring. The company designs, develops and manufactures prosthetic heart valves and related delivery systems used in both surgical and minimally invasive (transcatheter) procedures. Its portfolio addresses a range of valvular conditions, with an emphasis on technologies that enable transcatheter aortic valve replacement (TAVR) as an alternative to open-heart surgery.

In addition to transcatheter heart valves—including the widely recognized SAPIEN family—Edwards offers surgical tissue valves and ancillary devices used by cardiac surgeons, interventional cardiologists and hospital teams.

Further Reading Five stocks we like better than Edwards Lifesciences Confidence Is Back, But Earnings Show the Consumer Is Being Picky AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative? 3 Photonics Companies Making Quantum Tech Possible

Receive News & Ratings for Edwards Lifesciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edwards Lifesciences and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINECalifornia Public Employees Retirement System Buys 44,533 Shares of Entegris, Inc. $ENTG

NEXT HEADLINE »California Public Employees Retirement System Sells 7,774 Shares of Global Payments Inc. $GPN

New York, New York--(Newsfile Corp. - July 22, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Badger Meter, Inc. ("Badger Meter" or the "Company") (NYSE: BMI) on behalf of investors that purchased or otherwise acquired Badger Meter securities between April 18, 2024 and April 16, 2026 (the "Class Period").

CLICK HERE TO JOIN THE CASE

If you are an investor in Badger Meter and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (646) 315-9003.

DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than August 3, 2026 to serve as a lead plaintiff for the purported class. If you have losses we encourage you to contact us to learn more about the lead plaintiff process. You need not seek to become a lead plaintiff in order to share in any possible recovery.

On April 17, 2026, Badger Meter reported first quarter 2026 results, including a deceleration of sales. Specifically, total sales of $202.3 million for the quarter were "9% lower than the prior year's $222.2 million." Additionally, the Company stated with respect to its first quarter operating results that "Utility water sales declined 10% year-over-year, reflecting project timing and other softer short-cycle municipal ordering . . . ."

Following this news, the price of Badger Meter shares declined by $36.75 per share, or more than 24%, to close at $115.54 per share on April 17, 2026.

The complaint alleges that throughout the Class Period, Defendants misrepresented the drivers of Badger Meter's "record" financial results, demand for the Company's products, and its prospects for continued growth. During the Class Period, Defendants allegedly told investors that Badger Meter's strong financial results reflected "ongoing favorable industry trends," "secular growth drivers," and "solid operating execution." They also allegedly touted "strong" demand and said they were seeing "robust order pacing and a strong bid pipeline that positions us well for continued sales and earnings growth," and that Badger Meter possessed a "long runway" for growth.

According to the complaint, in truth, "Badger Meter's financial results during the Class Period were at least partially attributable to the Company's practice of pulling-forward customer orders to recognize revenue early, which concealed weakening demand and deteriorating near-term order trends. This practice also depleted revenue otherwise available for future periods, ultimately causing the disappointing financial results the Company later reported."

WHY CONTACT KAPLAN FOX?

Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented.

Kaplan Fox is widely regarded as one of the nation's premier plaintiffs' securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in In re Bank of America—the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act—$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in ATRS v. Allianz Global Investors, and a $475 million settlement in In re Merrill Lynch.

For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Past results do not guarantee future outcomes.

If you have any questions about this Notice, your rights, or your interests, please contact:

Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.

https://www.kaplanfox.com/case/badger-meter-inc-shareholder-alert-learn-more-now/

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/305968

Source: Kaplan Fox & Kilsheimer LLP

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Posted by Defense World Staff on Jul 22nd, 2026

Baader Bank Aktiengesellschaft boosted its position in shares of Howmet Aerospace Inc. (NYSE:HWM – Free Report) by 161.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,205 shares of the company’s stock after acquiring an additional 1,979 shares during the period. Baader Bank Aktiengesellschaft’s holdings in Howmet Aerospace were worth $694,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Norges Bank bought a new position in Howmet Aerospace during the fourth quarter valued at approximately $1,793,698,000. Price T Rowe Associates Inc. MD boosted its holdings in Howmet Aerospace by 27.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 16,632,206 shares of the company’s stock valued at $3,409,936,000 after acquiring an additional 3,531,700 shares during the period. Auto Owners Insurance Co grew its position in Howmet Aerospace by 20,402.0% during the 4th quarter. Auto Owners Insurance Co now owns 1,441,906 shares of the company’s stock worth $29,562,000 after acquiring an additional 1,434,873 shares during the last quarter. Goldman Sachs Group Inc. lifted its position in Howmet Aerospace by 27.8% in the fourth quarter. Goldman Sachs Group Inc. now owns 2,754,204 shares of the company’s stock valued at $564,667,000 after purchasing an additional 599,151 shares during the last quarter. Finally, Franklin Resources Inc. boosted its stake in shares of Howmet Aerospace by 56.3% during the fourth quarter. Franklin Resources Inc. now owns 1,433,811 shares of the company’s stock valued at $293,960,000 after purchasing an additional 516,570 shares during the period. Institutional investors own 90.46% of the company’s stock.

Howmet Aerospace Price Performance NYSE HWM opened at $278.98 on Wednesday. The stock has a market capitalization of $111.62 billion, a price-to-earnings ratio of 64.73, a PEG ratio of 2.14 and a beta of 1.19. Howmet Aerospace Inc. has a 1-year low of $169.45 and a 1-year high of $290.63. The company has a debt-to-equity ratio of 0.73, a current ratio of 2.44 and a quick ratio of 1.59. The business’s fifty day moving average price is $266.46 and its 200-day moving average price is $247.91.

Howmet Aerospace (NYSE:HWM – Get Free Report) last posted its quarterly earnings data on Thursday, May 7th. The company reported $1.22 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.11. The firm had revenue of $2.31 billion for the quarter, compared to analysts’ expectations of $2.24 billion. Howmet Aerospace had a return on equity of 29.27% and a net margin of 20.23%.The business’s quarterly revenue was up 19.1% on a year-over-year basis. During the same period in the previous year, the firm earned $0.86 EPS. Howmet Aerospace has set its FY 2026 guidance at 4.880-5.000 EPS and its Q2 2026 guidance at 1.220-1.240 EPS. On average, equities analysts predict that Howmet Aerospace Inc. will post 5.05 earnings per share for the current year.

Howmet Aerospace Dividend Announcement The company also recently declared a quarterly dividend, which was paid on Tuesday, May 26th. Investors of record on Friday, May 8th were paid a dividend of $0.12 per share. The ex-dividend date of this dividend was Friday, May 8th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.2%. Howmet Aerospace’s payout ratio is currently 11.14%.

Analyst Ratings Changes A number of research analysts recently issued reports on the company. KeyCorp started coverage on Howmet Aerospace in a report on Wednesday, March 25th. They set a “sector weight” rating on the stock. Sanford C. Bernstein restated an “outperform” rating and set a $318.00 price target on shares of Howmet Aerospace in a research report on Tuesday, June 16th. BNP Paribas Exane reiterated an “outperform” rating and issued a $340.00 price objective (up from $265.00) on shares of Howmet Aerospace in a report on Friday, May 8th. Citigroup upped their target price on shares of Howmet Aerospace from $303.00 to $311.00 and gave the stock a “buy” rating in a research report on Wednesday, July 1st. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $320.00 price target on shares of Howmet Aerospace in a research report on Friday, May 8th. Eighteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, Howmet Aerospace currently has an average rating of “Moderate Buy” and an average target price of $293.21.

Check Out Our Latest Research Report on HWM

Insider Activity In other news, EVP Neil Edward Marchuk sold 41,932 shares of the business’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $269.50, for a total transaction of $11,300,674.00. Following the completion of the sale, the executive vice president directly owned 65,105 shares of the company’s stock, valued at approximately $17,545,797.50. The trade was a 39.18% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.85% of the stock is owned by company insiders.

About Howmet Aerospace (Free Report)

Howmet Aerospace Inc is an industrial technology company that designs, manufactures and repairs engineered metal products for the aerospace, transportation and industrial markets. Its product portfolio includes precision castings and forgings, engineered fasteners, seamless rolled rings, and complex components for turbine engines, airframes and industrial gas turbines. The company also provides aftermarket services such as component repair, overhaul and parts distribution to support the operating fleet of commercial and military customers.

Howmet serves a global customer base of original equipment manufacturers (OEMs) and aftermarket operators, with manufacturing, service and distribution facilities across North America, Europe and Asia.

Featured Articles Five stocks we like better than Howmet Aerospace Confidence Is Back, But Earnings Show the Consumer Is Being Picky AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative? 3 Photonics Companies Making Quantum Tech Possible

Receive News & Ratings for Howmet Aerospace Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Howmet Aerospace and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAcumen Wealth Advisors LLC Has $828,000 Stake in Williams Companies, Inc. (The) $WMB

NEXT HEADLINE »11,836 Shares in Bank of America Corporation $BAC Bought by Baader Bank Aktiengesellschaft

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Considering buying DOCN stock? Here’s what analysts think:

Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

California Public Employees Retirement System increased its position in shares of BorgWarner Inc. (NYSE:BWA – Free Report) by 12.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 532,927 shares of the auto parts company’s stock after acquiring an additional 58,960 shares during the period. California Public Employees Retirement System owned about 0.26% of BorgWarner worth $28,917,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Dimensional Fund Advisors LP increased its stake in BorgWarner by 1.5% during the fourth quarter. Dimensional Fund Advisors LP now owns 11,961,482 shares of the auto parts company’s stock worth $538,996,000 after purchasing an additional 178,853 shares during the period. AQR Capital Management LLC boosted its stake in shares of BorgWarner by 22.7% in the fourth quarter. AQR Capital Management LLC now owns 9,222,352 shares of the auto parts company’s stock valued at $415,559,000 after purchasing an additional 1,703,576 shares during the period. State Street Corp grew its holdings in shares of BorgWarner by 5.3% in the second quarter. State Street Corp now owns 7,633,760 shares of the auto parts company’s stock valued at $255,578,000 after purchasing an additional 380,942 shares in the last quarter. LSV Asset Management increased its stake in BorgWarner by 6.7% during the 4th quarter. LSV Asset Management now owns 6,446,541 shares of the auto parts company’s stock worth $290,481,000 after buying an additional 402,887 shares during the period. Finally, Geode Capital Management LLC increased its stake in BorgWarner by 10.9% during the 4th quarter. Geode Capital Management LLC now owns 4,297,717 shares of the auto parts company’s stock worth $193,695,000 after buying an additional 423,933 shares during the period. 95.67% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets In other news, VP Isabelle Mckenzie sold 3,500 shares of the stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $63.35, for a total value of $221,725.00. Following the transaction, the vice president owned 57,828 shares in the company, valued at approximately $3,663,403.80. This represents a 5.71% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Tania Wingfield sold 5,000 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $63.24, for a total value of $316,200.00. Following the sale, the executive vice president directly owned 35,365 shares in the company, valued at $2,236,482.60. This trade represents a 12.39% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 67,500 shares of company stock valued at $4,310,115. 0.76% of the stock is owned by insiders.

BorgWarner Trading Up 3.2% Shares of NYSE:BWA opened at $63.60 on Wednesday. BorgWarner Inc. has a 52 week low of $34.27 and a 52 week high of $78.82. The company’s 50 day moving average is $68.03 and its two-hundred day moving average is $58.69. The company has a market cap of $13.05 billion, a PE ratio of 37.63, a P/E/G ratio of 1.32 and a beta of 1.09. The company has a current ratio of 2.13, a quick ratio of 1.75 and a debt-to-equity ratio of 0.69.

BorgWarner (NYSE:BWA – Get Free Report) last released its quarterly earnings data on Wednesday, May 6th. The auto parts company reported $1.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.16 by $0.08. The business had revenue of $3.53 billion during the quarter, compared to analysts’ expectations of $3.50 billion. BorgWarner had a net margin of 2.53% and a return on equity of 18.36%. The company’s revenue for the quarter was up .5% on a year-over-year basis. During the same period in the previous year, the company earned $1.11 EPS. BorgWarner has set its FY 2026 guidance at 5.000-5.200 EPS. Equities analysts predict that BorgWarner Inc. will post 5.16 earnings per share for the current fiscal year.

BorgWarner Announces Dividend The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 1.1%. The ex-dividend date of this dividend was Monday, June 1st. BorgWarner’s dividend payout ratio is currently 40.24%.

Analysts Set New Price Targets Several research firms have commented on BWA. Morgan Stanley boosted their price target on shares of BorgWarner from $60.00 to $67.00 and gave the stock an “equal weight” rating in a research note on Wednesday, May 27th. Wolfe Research reiterated an “outperform” rating and issued a $95.00 price objective on shares of BorgWarner in a research note on Wednesday, June 3rd. TD Cowen lifted their target price on BorgWarner from $66.00 to $67.00 and gave the company a “hold” rating in a report on Thursday, May 7th. UBS Group raised BorgWarner from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $61.00 to $95.00 in a research note on Wednesday, June 10th. Finally, Barclays upped their price target on BorgWarner from $75.00 to $83.00 and gave the stock an “overweight” rating in a report on Thursday, July 9th. Nine research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $74.57.

View Our Latest Analysis on BWA

BorgWarner Profile (Free Report)

BorgWarner Inc is a global automotive supplier specializing in propulsion and drivetrain solutions for combustion, hybrid and electric vehicles. The company’s product portfolio includes turbochargers, thermal management systems, transmission components, e-Propulsion modules and advanced fuel-efficiency technologies. BorgWarner serves original equipment manufacturers (OEMs) across passenger cars, light trucks and commercial vehicles, supporting both legacy internal-combustion engines and emerging electrification trends.

Founded in 1928 through the merger of several driveline companies, BorgWarner has grown through strategic acquisitions and continuous investment in research and development.

Further Reading Five stocks we like better than BorgWarner Confidence Is Back, But Earnings Show the Consumer Is Being Picky AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative? 3 Photonics Companies Making Quantum Tech Possible

Receive News & Ratings for BorgWarner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BorgWarner and related companies with MarketBeat.com's FREE daily email newsletter.

NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Planet Fitness, Inc. (NYSE:PLNT) for potential securities fraud after its significant stock drop. If you invested in Planet Fitness, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/planet-fitness-class-action-lawsuit.

Cal-Maine Foods swung to a fiscal fourth-quarter loss of $35.9 million, compared with a profit of $342.5 million a year ago.

Posted by Defense World Staff on Jul 22nd, 2026

California Public Employees Retirement System decreased its position in shares of Equifax, Inc. (NYSE:EFX – Free Report) by 26.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 160,205 shares of the credit services provider’s stock after selling 56,857 shares during the period. California Public Employees Retirement System owned 0.13% of Equifax worth $28,848,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of EFX. Cullen Frost Bankers Inc. bought a new stake in Equifax during the 4th quarter valued at approximately $25,000. Ameriflex Group Inc. increased its position in Equifax by 612.5% in the 4th quarter. Ameriflex Group Inc. now owns 114 shares of the credit services provider’s stock worth $25,000 after buying an additional 98 shares during the period. Kemnay Advisory Services Inc. acquired a new position in shares of Equifax during the fourth quarter worth approximately $26,000. Reflection Asset Management acquired a new position in shares of Equifax during the fourth quarter worth approximately $26,000. Finally, State of Wyoming bought a new stake in shares of Equifax in the second quarter valued at approximately $34,000. 96.20% of the stock is currently owned by institutional investors.

Key Stories Impacting Equifax Here are the key news stories impacting Equifax this week:

Positive Sentiment: Equifax posted Q2 2026 EPS of $2.25, topping estimates, while revenue of $1.70 billion rose 11% year over year and matched Wall Street expectations. The company also highlighted strength in USIS, mortgage, and verification businesses, and announced an agreement to acquire Círculo de Crédito, which could expand its credit data footprint. Article Title Positive Sentiment: Management said early AI and agentic-automation gains are helping drive efficiency, and it doubled its expected three-year AI-driven cost savings target to $150 million from $75 million, a potentially meaningful margin tailwind over time. Article Title Neutral Sentiment: Free cash flow remained strong at $326 million for the first six months, and the company returned $366 million to shareholders, supporting the longer-term investment case even as near-term sentiment stays cautious. Article Title Negative Sentiment: Investor reaction has been pressured by Equifax’s weaker-than-expected Q3 and full-year 2026 guidance, which came in below consensus and suggests headwinds from a tough mortgage market and broader macro conditions. Article Title Negative Sentiment: Margins were also hit by a legal settlement accrual tied to a previously disclosed coding issue, adding another overhang as analysts noted the company’s near-term outlook appears less exciting than the quarter’s operating results. Article Title Insider Activity In other Equifax news, CEO Mark W. Begor sold 37,791 shares of the firm’s stock in a transaction dated Friday, April 24th. The shares were sold at an average price of $172.40, for a total transaction of $6,515,168.40. Following the completion of the transaction, the chief executive officer owned 271,730 shares in the company, valued at $46,846,252. This trade represents a 12.21% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Chad M. Borton sold 2,455 shares of Equifax stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $173.89, for a total value of $426,899.95. Following the sale, the executive vice president directly owned 29,518 shares in the company, valued at $5,132,885.02. The trade was a 7.68% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 1.70% of the company’s stock.

Analysts Set New Price Targets EFX has been the topic of several research analyst reports. Jefferies Financial Group lowered their price objective on shares of Equifax from $220.00 to $200.00 and set a “buy” rating on the stock in a research note on Friday, April 24th. The Goldman Sachs Group reissued a “neutral” rating and issued a $182.00 price target on shares of Equifax in a report on Tuesday. Morgan Stanley decreased their price target on shares of Equifax from $244.00 to $243.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 28th. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Equifax from $225.00 to $217.00 in a report on Thursday, July 9th. Finally, Weiss Ratings upgraded shares of Equifax from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 16th. Thirteen investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $221.63.

Get Our Latest Analysis on EFX

Equifax Stock Down 4.4% Shares of EFX stock opened at $172.23 on Wednesday. The stock has a market cap of $20.51 billion, a P/E ratio of 30.32, a price-to-earnings-growth ratio of 1.36 and a beta of 1.32. Equifax, Inc. has a one year low of $150.74 and a one year high of $271.84. The stock has a fifty day moving average price of $165.31 and a 200 day moving average price of $183.40. The company has a debt-to-equity ratio of 0.89, a current ratio of 0.61 and a quick ratio of 0.61.

Equifax (NYSE:EFX – Get Free Report) last posted its quarterly earnings results on Tuesday, July 21st. The credit services provider reported $2.25 earnings per share for the quarter, topping analysts’ consensus estimates of $2.20 by $0.05. The firm had revenue of $1.70 billion for the quarter, compared to the consensus estimate of $1.70 billion. Equifax had a net margin of 11.12% and a return on equity of 20.41%. The business’s revenue was up 10.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.00 earnings per share. Equifax has set its Q3 2026 guidance at 2.150-2.250 EPS and its FY 2026 guidance at 8.390-8.690 EPS. Analysts predict that Equifax, Inc. will post 8.56 earnings per share for the current year.

Equifax Announces Dividend The firm also recently announced a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Friday, May 22nd were paid a $0.56 dividend. The ex-dividend date of this dividend was Friday, May 22nd. This represents a $2.24 dividend on an annualized basis and a yield of 1.3%. Equifax’s payout ratio is presently 39.44%.

Equifax Profile (Free Report)

Equifax Inc (NYSE: EFX) is a global data, analytics and technology company that specializes in consumer and commercial credit reporting, decisioning tools and identity solutions. Headquartered in Atlanta, Georgia, Equifax is one of the three major consumer credit reporting agencies in the United States and provides credit information and related services to lenders, employers, governments and consumers worldwide.

The company’s offerings include consumer credit reports and scores, credit monitoring and identity protection services, and a range of business-oriented products for risk management, fraud detection and compliance.

Further Reading Five stocks we like better than Equifax Confidence Is Back, But Earnings Show the Consumer Is Being Picky AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative? 3 Photonics Companies Making Quantum Tech Possible Want to see what other hedge funds are holding EFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Equifax, Inc. (NYSE:EFX – Free Report).

Receive News & Ratings for Equifax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINECalifornia Public Employees Retirement System Reduces Stake in Pinnacle West Capital Corporation $PNW

NEXT HEADLINE »California Public Employees Retirement System Reduces Position in Assurant, Inc. $AIZ

TE Connectivity reported better-than-expected quarterly earnings and gave solid guidance for the coming quarter.

Posted by Defense World Staff on Jul 22nd, 2026

Dimensional Fund Advisors LP grew its stake in Arch Capital Group Ltd. (NASDAQ:ACGL – Free Report) by 2.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,173,885 shares of the insurance provider’s stock after purchasing an additional 117,929 shares during the quarter. Dimensional Fund Advisors LP owned approximately 1.17% of Arch Capital Group worth $400,643,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Elyxium Wealth LLC purchased a new position in Arch Capital Group in the 4th quarter valued at about $27,000. WealthCollab LLC boosted its holdings in Arch Capital Group by 410.3% in the 3rd quarter. WealthCollab LLC now owns 296 shares of the insurance provider’s stock worth $27,000 after buying an additional 238 shares during the last quarter. JPL Wealth Management LLC purchased a new stake in Arch Capital Group during the 3rd quarter worth approximately $28,000. Aventura Private Wealth LLC acquired a new position in shares of Arch Capital Group during the fourth quarter valued at approximately $30,000. Finally, TD Waterhouse Canada Inc. raised its holdings in shares of Arch Capital Group by 72.7% during the fourth quarter. TD Waterhouse Canada Inc. now owns 323 shares of the insurance provider’s stock valued at $31,000 after acquiring an additional 136 shares during the last quarter. Hedge funds and other institutional investors own 89.07% of the company’s stock.

Wall Street Analyst Weigh In A number of brokerages have recently issued reports on ACGL. Barclays lifted their price target on Arch Capital Group from $104.00 to $106.00 and gave the stock an “equal weight” rating in a research note on Wednesday, April 8th. Mizuho increased their price objective on Arch Capital Group from $101.00 to $104.00 and gave the company a “neutral” rating in a research note on Thursday, July 9th. Cantor Fitzgerald restated a “neutral” rating and issued a $102.00 price objective (up from $100.00) on shares of Arch Capital Group in a report on Thursday, July 9th. Atlantic Securities set a $126.00 target price on shares of Arch Capital Group in a research note on Wednesday, July 15th. Finally, Weiss Ratings lowered shares of Arch Capital Group from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday, May 18th. Eight equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $109.82.

View Our Latest Research Report on ACGL

Arch Capital Group Price Performance NASDAQ:ACGL opened at $100.55 on Wednesday. Arch Capital Group Ltd. has a one year low of $82.44 and a one year high of $105.09. The stock has a market cap of $35.13 billion, a PE ratio of 7.72, a P/E/G ratio of 5.07 and a beta of 0.31. The company has a debt-to-equity ratio of 0.15, a quick ratio of 0.55 and a current ratio of 0.55. The stock has a 50 day moving average price of $95.38 and a 200 day moving average price of $95.70.

Arch Capital Group (NASDAQ:ACGL – Get Free Report) last released its quarterly earnings data on Tuesday, March 31st. The insurance provider reported $2.50 earnings per share for the quarter. Arch Capital Group had a return on equity of 17.61% and a net margin of 24.64%.The company had revenue of $4.52 billion for the quarter. Equities research analysts expect that Arch Capital Group Ltd. will post 9.35 EPS for the current fiscal year.

Insider Activity In other news, Director Daniel Joseph Houston acquired 5,300 shares of the business’s stock in a transaction that occurred on Thursday, April 30th. The stock was purchased at an average cost of $94.08 per share, for a total transaction of $498,624.00. Following the completion of the transaction, the director owned 9,915 shares in the company, valued at approximately $932,803.20. This trade represents a 114.84% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Brian S. Posner sold 3,000 shares of Arch Capital Group stock in a transaction dated Wednesday, June 3rd. The stock was sold at an average price of $19.66, for a total transaction of $58,980.00. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 3.30% of the company’s stock.

About Arch Capital Group (Free Report)

Arch Capital Group Ltd. (NASDAQ: ACGL) is a Bermuda-based insurance and reinsurance holding company that underwrites a broad range of property and casualty, mortgage, and specialty risk products. The company operates through a group of underwriting subsidiaries and platforms to provide insurance, reinsurance and related risk solutions tailored to commercial, institutional and individual clients.

Arch’s product mix includes treaty and facultative reinsurance, primary casualty and property insurance, mortgage insurance and other specialty lines.

Featured Articles Five stocks we like better than Arch Capital Group Confidence Is Back, But Earnings Show the Consumer Is Being Picky AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative? 3 Photonics Companies Making Quantum Tech Possible Want to see what other hedge funds are holding ACGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arch Capital Group Ltd. (NASDAQ:ACGL – Free Report).

Receive News & Ratings for Arch Capital Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Capital Group and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINECalifornia Public Employees Retirement System Sells 28,660 Shares of Trimble Inc. $TRMB

NEXT HEADLINE »Toll Brothers Inc. $TOL Shares Bought by Dimensional Fund Advisors LP

GREENSBORO, N.C.--(BUSINESS WIRE)---- $KTB--Kontoor Brands, Inc. (NYSE: KTB) today announced plans to release its second quarter 2026 financial results on Wednesday, August 12, 2026, at approximately 6:50 a.m. ET. Following the news release, Kontoor management will host a conference call at approximately 8:30 a.m. ET to review results. The conference call will be broadcast live and accessible at kontoorbrands.com/investors. For those unable to listen to the live broadcast, an archived version will be av.

Posted by Defense World Staff on Jul 22nd, 2026

California Public Employees Retirement System lowered its position in shares of Equity Lifestyle Properties, Inc. (NYSE:ELS – Free Report) by 8.3% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 453,682 shares of the real estate investment trust’s stock after selling 41,322 shares during the quarter. California Public Employees Retirement System owned about 0.23% of Equity Lifestyle Properties worth $28,319,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD raised its holdings in Equity Lifestyle Properties by 303.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 15,948,613 shares of the real estate investment trust’s stock valued at $966,648,000 after buying an additional 11,999,874 shares during the period. Daiwa Securities Group Inc. grew its stake in Equity Lifestyle Properties by 253.7% during the third quarter. Daiwa Securities Group Inc. now owns 3,147,048 shares of the real estate investment trust’s stock worth $191,025,000 after buying an additional 2,257,299 shares during the period. Cohen & Steers Inc. increased its position in shares of Equity Lifestyle Properties by 26.8% in the fourth quarter. Cohen & Steers Inc. now owns 10,614,040 shares of the real estate investment trust’s stock worth $643,331,000 after acquiring an additional 2,246,622 shares in the last quarter. Norges Bank acquired a new stake in shares of Equity Lifestyle Properties in the fourth quarter worth $125,352,000. Finally, Royal London Asset Management Ltd. raised its stake in shares of Equity Lifestyle Properties by 1,520.4% in the 2nd quarter. Royal London Asset Management Ltd. now owns 1,771,803 shares of the real estate investment trust’s stock valued at $109,267,000 after acquiring an additional 1,662,458 shares during the period. Institutional investors and hedge funds own 97.21% of the company’s stock.

Equity Lifestyle Properties Stock Down 0.6% Shares of NYSE:ELS opened at $64.88 on Wednesday. The company has a market capitalization of $12.58 billion, a price-to-earnings ratio of 32.44, a price-to-earnings-growth ratio of 3.97 and a beta of 0.66. The company has a 50 day moving average of $63.46 and a two-hundred day moving average of $64.09. Equity Lifestyle Properties, Inc. has a 52-week low of $58.15 and a 52-week high of $69.00. The company has a quick ratio of 0.04, a current ratio of 0.04 and a debt-to-equity ratio of 0.29.

Equity Lifestyle Properties (NYSE:ELS – Get Free Report) last posted its earnings results on Wednesday, April 22nd. The real estate investment trust reported $0.56 EPS for the quarter, missing analysts’ consensus estimates of $0.84 by ($0.28). The firm had revenue of $397.62 million for the quarter, compared to analyst estimates of $395.71 million. Equity Lifestyle Properties had a return on equity of 21.22% and a net margin of 24.99%.The company’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same period in the previous year, the firm posted $0.57 earnings per share. As a group, analysts forecast that Equity Lifestyle Properties, Inc. will post 3.18 earnings per share for the current fiscal year.

Equity Lifestyle Properties Dividend Announcement The company also recently declared a quarterly dividend, which was paid on Friday, July 10th. Investors of record on Friday, June 26th were issued a dividend of $0.5425 per share. This represents a $2.17 dividend on an annualized basis and a yield of 3.3%. The ex-dividend date of this dividend was Friday, June 26th. Equity Lifestyle Properties’s dividend payout ratio (DPR) is presently 108.50%.

Analysts Set New Price Targets Several research firms recently weighed in on ELS. Jefferies Financial Group upgraded shares of Equity Lifestyle Properties to a “strong-buy” rating in a report on Friday, June 26th. Deutsche Bank Aktiengesellschaft upgraded Equity Lifestyle Properties from a “hold” rating to a “buy” rating and set a $72.00 price target for the company in a report on Wednesday, April 15th. Mizuho initiated coverage on Equity Lifestyle Properties in a research report on Tuesday, March 31st. They issued an “outperform” rating and a $72.00 price objective on the stock. Wall Street Zen upgraded Equity Lifestyle Properties from a “sell” rating to a “hold” rating in a research note on Saturday, April 11th. Finally, Odeon Capital Group set a $65.00 target price on Equity Lifestyle Properties in a research report on Thursday, July 9th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $68.70.

Read Our Latest Analysis on Equity Lifestyle Properties

Equity Lifestyle Properties Profile (Free Report)

Equity Lifestyle Properties, Inc (NYSE: ELS) is a publicly traded real estate investment trust specializing in the acquisition, development, ownership and operation of manufactured home communities and recreational vehicle resorts. The company’s portfolio includes more than 450 properties across the United States and Canada, serving over 200,000 residents and visitors. ELS organizes its operations into two primary segments: manufactured housing communities, which provide long-term housing solutions, and upscale RV and seasonal resorts designed for leisure travelers and seasonal patrons.

In its manufactured home division, ELS offers home-site leases combined with community amenities such as landscaped common areas, clubhouses, swimming pools and organized resident events.

Recommended Stories Five stocks we like better than Equity Lifestyle Properties Confidence Is Back, But Earnings Show the Consumer Is Being Picky AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative? 3 Photonics Companies Making Quantum Tech Possible

Receive News & Ratings for Equity Lifestyle Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equity Lifestyle Properties and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBalefire LLC Decreases Stake in Ball Corporation $BALL

NEXT HEADLINE »California Public Employees Retirement System Trims Stock Position in Genuine Parts Company $GPC

Coleman's First-Ever Music Partnership Brings Kane Brown's Signature Style to Summer's Outdoor Must-Haves

Coleman® launches the limited-edition Coleman x Kane Brown Collection, the debut release from the brand's first-ever music partnership and multi-year collaboration with the global superstar Inspired by Brown's life on tour and love of the outdoors, the collection brings his signature style to a Steel-Belted Hard Cooler, Soft Cooler Sling, Stainless-Steel Tumbler and upcoming Snap 'N Go™ Hard Collapsible Cooler Multi-year collaboration unites outdoor recreation, music and fan experiences through future product launches, content and activations , /PRNewswire/ -- Today, Coleman® and Kane Brown announced the launch of the limited-edition Coleman x Kane Brown Collection, the debut release from the brand's first-ever music partnership and long-term collaboration with award-winning, multi-platinum country global superstar Kane Brown. Inspired by Brown's life on tour, love for the outdoors, and favorite summer traditions, the collection features a custom Steel-Belted Hard Cooler, Soft Cooler Sling, and Stainless-Steel Tumbler, with a Snap 'N Go™ Hard Collapsible Cooler arriving later this year. Reimagining Coleman classics through Brown's signature style, the limited-edition collection offers fans a collectible take on outdoor essentials featuring Kane-inspired design details and his signature "KB" branding.

Coleman® and Kane Brown Celebrate Multi-Year Partnership with the Launch of Limited-Edition Collection.

Coleman® and Kane Brown Celebrate Multi-Year Partnership with the Launch of Limited-Edition Collection. A longtime outdoorsman, Brown has incorporated Coleman products into both his personal life and professional life on the road. The collaboration builds on Coleman's sponsorship of The High Road Tour, where Coleman gear traveled alongside Brown and his crew, appearing backstage and helping power the moments between performances. As Coleman's official ambassador, Brown will influence product development and activations while introducing the brand to new audiences across music, culture, and lifestyle.

"I love the line I was able to create with Coleman," said Kane Brown. "From the cups that we use on stage every night to toast the fans to the limited-edition Snap 'N Go cooler, coming this Fall. I have really enjoyed working with the Coleman team on this collection and showing fans the products I use at my home, on the road, and at the beach. I hope everyone enjoys them as much as I do."

"As our first country music brand ambassador, Kane embodies our brand purpose by inspiring the next generation to forge their own outdoor traditions," said Jimmy Jia, Global Vice President of Brand Management, Outdoor & Recreation at Newell Brands. "From tailgates to backyard parties to life on the road with his crew, he uses our products in authentic ways every day. Together, we've created an exclusive capsule that reflects Coleman and Kane's distinct trailblazing style."

Kane Brown's Summer Essentials
The inaugural Coleman x Kane Brown Collection features a Steel-Belted Hard Cooler, Soft Cooler Sling, and Stainless-Steel Tumbler, with a Snap 'N Go™ Hard Collapsible Cooler arriving later this year. Drawing inspiration from tailgates before shows, beach trips with family, and life on tour, Brown helped shape the collection's colors, graphics, and product selections to reflect how he spends his time outdoors. Each piece features unique colorways and design details personally selected by Brown, complete with his iconic "KB" logo or signature, offering fans functional outdoor essentials inspired by his life both on the road and at home.

Kane's Steel-Belted Hard Cooler: Durable steel cooler with 4-day ice retention, 85-can capacity, and built-in bottle opener, featuring Kane's etched signature ($239.99) Kane's Soft Cooler Sling: Hands-free cooler bag with adjustable sling, 6-can capacity, and 12+ hours of cooling, featuring Kane's iconic "KB" logo ($21.99) Kane's Stainless-Steel Tumbler: Vacuum-insulated 20oz tumbler that keeps drinks cold for 18 hours or hot for 6 hours, featuring an iridescent finish, sweatproof design and splash-resistant lid, and iconic "KB" logo ($34.99) Coming Soon: Kane's Snap 'N Go Hard Collapsible Cooler: Portable 45QT collapsible cooler, with 2-day ice retention, 76-can capacity, that folds to one-third its size, complete with exclusive Kane Brown typography ($229.99). Visit Coleman.com today to sign-up for launch updates. The limited-edition Coleman x Kane Brown Collection will be available beginning July 22, 2026, while supplies last on Coleman.com.

An Exclusive First Look
To celebrate the launch, Coleman and Brown hosted an exclusive preview event at Kane Brown's Broadway bar in Nashville, where guests received an immersive first look at the limited-edition collection through hands-on product experiences and outdoor-inspired activations. Attendees included Brown's friends and family, who joined him in raising a toast to the collaboration ahead of its official debut.

The Next Chapter of Coleman x Kane Brown
The collection marks the first chapter of Coleman and Brown's broader multi-year collaboration, which will continue to bring together outdoor recreation, music, and fan engagement through future products, experiences, and content. Later this year, the collection will expand with a highly anticipated custom Kane Brown-inspired Snap 'N Go™ cooler. Fans are invited to sign up for launch updates now on Coleman.com.

For more information, visit Coleman.com or follow @ColemanUSA on social media. And to keep up with Kane Brown, follow INSTAGRAM, TIKTOK, and FACEBOOK.

ABOUT COLEMAN
For over 120 years, The Coleman Company, Inc. has been a trusted partner for unforgettable moments outside. Whether you're cheering on your team or enjoying a cookout with friends, Coleman makes every outdoor adventure more memorable. We believe that the joy of outdoor gatherings brings people closer together—strengthening bonds and creating lasting memories. To learn more, visit coleman.com and follow us on Instagram.

ABOUT NEWELL BRANDS
Newell Brands (NASDAQ: NWL) is a leading global consumer goods company with a strong portfolio of well-known brands, including Rubbermaid, Sharpie®, Graco®, Coleman®, Rubbermaid Commercial Products®, Yankee Candle®, Paper Mate®, FoodSaver®, Dymo®, EXPO®, Elmer's®, Oster®, NUK®, Spontex® and Campingaz®. Newell Brands is focused on delighting consumers by lighting up everyday moments.

ABOUT KANE BROWN: 
Named "the future of country music" (Billboard), Multi-Platinum-selling, award-winning singer/songwriter Kane Brown "didn't fit the country music mold. So he made his own." (The New York Times). Kicking off 2026 strong, Brown just released his song "Woman," which follows the success of his widely acclaimed 2025 record, The High Road. Listen to the song HERE.

Brown first broke onto the scene with the arrival of his self-titled, 2X Platinum debut album (2016), where he became the first artist ever to lead all five of Billboard's main country charts simultaneously and topped the Billboard Top Country Albums chart for more than 13 weeks and earned two of the most-streamed country songs of all time (chart-topping singles Diamond Certified "Heaven," and "What Ifs"). His album Experiment (2018) hit #1 on the Billboard Top 200 all genre list-becoming the first Country artist in more than 24 years to top the chart with a sophomore album. Brown released his multi-song project Mixtape Vol. 1- which earned Brown an ACM Award nomination for Album of the Year (2021) and an ACM win for "Video of the Year." 

Expanding beyond music, Brown has stepped into film and television, guest starring on 9-1-1: Nashville, and serving as executive producer on Thank God: Christmas at Keller Ranch. He is also the founder of Verse2, a publishing venture in partnership with Sony Music Publishing, further solidifying his growing influence across the industry. This summer, Brown also opened his new Nashville bar, Kane Brown's On Broadway, marking his latest entrepreneurial venture and expansion in Music City.

Named to Time's 100 most influential people in the world (2021), Kane Brown has ascended from independently built social media notability to an ACM Entertainer of the Year nominee (2023 & 2024) - and has become one of country music's most accomplished mainstays and global entertainers.

With 13 chart-topping No. 1 singles at Country radio, internationally sold out tours and stadium dates, Brown continues to garner a series of milestones that continue to expand the perception of country music and break musical boundaries- from being named to the Time100 list (2021) to becoming the first black artist in history to headline and sell out Boston's historic Fenway Park (2023) to his win ACM Video of the Year (2021) and multiple ACM, Billboard, AMA, CMT and People's Choice Award nominations, including most recently, his recognition by the People's Choice Country Awards with a Country Champion Award win.

Brown has also earned numerous accolades for his ongoing work with The Boys & Girls Club, including the Country Radio Seminar (CRS) Humanitarian Award and the Champion of Youth Award from The Boys & Girls Club.

MEDIA CONTACTS:
Alison Brod Marketing + Communications
[email protected]

PRESS CONTACTS:
Carleen Donovan, [email protected]
Kaeleah Isaac, [email protected]

SOURCE Newell Brands

FARNBOROUGH, England--(BUSINESS WIRE)---- $ACHR #Archer--Archer Aviation (NYSE: ACHR) today announced Halo, the commercial variant of a jointly-developed dual-use platform built to serve both defense and commercial applications. Anduril unveiled Thunder, the defense variant of the platform, on Monday at the Farnborough International Airshow. The two variants share the same airframe, hybrid powertrain and core systems, with configurable payload depending on mission requirements. Archer Technology Stack This new d.

Posted by Defense World Staff on Jul 22nd, 2026

California Public Employees Retirement System increased its position in shares of East West Bancorp, Inc. (NASDAQ:EWBC – Free Report) by 8.0% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 279,413 shares of the financial services provider’s stock after buying an additional 20,588 shares during the quarter. California Public Employees Retirement System owned about 0.20% of East West Bancorp worth $29,830,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in EWBC. Oak Thistle LLC purchased a new stake in East West Bancorp in the 4th quarter valued at $1,530,000. Mach 1 Financial Group LLC acquired a new position in East West Bancorp in the fourth quarter valued at $1,044,000. Northwestern Mutual Wealth Management Co. increased its stake in East West Bancorp by 84,090.3% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 5,311,566 shares of the financial services provider’s stock valued at $596,967,000 after purchasing an additional 5,305,257 shares during the period. Geode Capital Management LLC raised its holdings in shares of East West Bancorp by 1.0% in the fourth quarter. Geode Capital Management LLC now owns 2,825,161 shares of the financial services provider’s stock valued at $319,523,000 after buying an additional 27,402 shares during the last quarter. Finally, SG Americas Securities LLC raised its holdings in shares of East West Bancorp by 141.2% in the fourth quarter. SG Americas Securities LLC now owns 128,368 shares of the financial services provider’s stock valued at $14,427,000 after buying an additional 75,147 shares during the last quarter. Hedge funds and other institutional investors own 89.53% of the company’s stock.

East West Bancorp Stock Down 0.4% Shares of NASDAQ:EWBC opened at $133.40 on Wednesday. East West Bancorp, Inc. has a fifty-two week low of $92.67 and a fifty-two week high of $136.24. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.34. The firm’s 50-day simple moving average is $127.49 and its 200-day simple moving average is $119.21. The company has a market cap of $18.28 billion, a price-to-earnings ratio of 13.33, a PEG ratio of 1.54 and a beta of 0.94.

East West Bancorp (NASDAQ:EWBC – Get Free Report) last posted its quarterly earnings results on Tuesday, July 21st. The financial services provider reported $2.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.61 by $0.02. The firm had revenue of $791.14 million during the quarter, compared to analysts’ expectations of $784.47 million. East West Bancorp had a net margin of 29.59% and a return on equity of 16.00%. During the same period in the prior year, the company posted $2.24 earnings per share. As a group, equities research analysts predict that East West Bancorp, Inc. will post 10.56 earnings per share for the current year.

Insiders Place Their Bets In related news, Vice Chairman Douglas Paul Krause sold 10,000 shares of the company’s stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $123.50, for a total transaction of $1,235,000.00. Following the transaction, the insider owned 46,974 shares of the company’s stock, valued at $5,801,289. This represents a 17.55% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Irene H. Oh sold 11,211 shares of the firm’s stock in a transaction on Thursday, June 11th. The shares were sold at an average price of $129.00, for a total value of $1,446,219.00. Following the completion of the sale, the insider directly owned 85,998 shares of the company’s stock, valued at approximately $11,093,742. This trade represents a 11.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 54,311 shares of company stock worth $6,784,711. Company insiders own 0.94% of the company’s stock.

Key Headlines Impacting East West Bancorp Here are the key news stories impacting East West Bancorp this week:

Positive Sentiment: East West Bancorp reported Q2 2026 EPS of $2.63, ahead of the $2.61 consensus estimate, and earnings rose from $2.24 a year ago. East West Bancorp earnings report and conference call link Positive Sentiment: The company said net income reached $364 million and total revenue hit a record, signaling strong operating performance. East West Bancorp Q2 2026 results press release Positive Sentiment: Loans and deposits both reached new records at $59.0 billion and $70.1 billion, respectively, showing continued business expansion and funding strength. East West Bancorp Q2 2026 results press release Positive Sentiment: Profitability remained solid, with return on average common equity of 16.0% and book value per share up 13% year over year. East West Bancorp Q2 2026 results press release Neutral Sentiment: Several recap articles and the earnings call transcript focused on the same core message: East West Bancorp beat expectations and delivered record revenue, reinforcing the upbeat reaction. East West Bancorp Q2 2026 earnings call transcript Wall Street Analysts Forecast Growth A number of research firms recently issued reports on EWBC. Truist Financial raised their price target on East West Bancorp from $128.00 to $136.00 and gave the stock a “hold” rating in a report on Friday, July 10th. Cantor Fitzgerald upped their price objective on East West Bancorp from $137.00 to $150.00 and gave the company an “overweight” rating in a research note on Wednesday, July 15th. TD Cowen increased their price objective on East West Bancorp from $137.00 to $143.00 and gave the stock a “buy” rating in a research report on Thursday, April 23rd. Wall Street Zen downgraded East West Bancorp from a “hold” rating to a “sell” rating in a research note on Saturday, July 4th. Finally, Citigroup boosted their target price on East West Bancorp from $145.00 to $154.00 and gave the company a “buy” rating in a report on Thursday, June 25th. Ten investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, East West Bancorp currently has a consensus rating of “Moderate Buy” and a consensus target price of $138.31.

Read Our Latest Research Report on EWBC

East West Bancorp Company Profile (Free Report)

East West Bancorp, Inc is a bank holding company and the parent of East West Bank, one of the largest independent banks headquartered in Southern California. As a full-service commercial bank, it provides a broad range of financial products and services to business and individual customers, including commercial and residential real estate lending, working capital lines of credit, trade finance, and deposit and treasury management services. The company caters to both large and middle-market businesses, leveraging its expertise to serve clients engaged in cross-border trade and investment between the United States and Greater China.

Founded in Los Angeles in the early 1970s, East West Bank has grown steadily through organic expansion and strategic branch openings.

See Also Five stocks we like better than East West Bancorp Confidence Is Back, But Earnings Show the Consumer Is Being Picky AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative? 3 Photonics Companies Making Quantum Tech Possible

Receive News & Ratings for East West Bancorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for East West Bancorp and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINECalifornia Public Employees Retirement System Has $28.16 Million Holdings in RBC Bearings Incorporated $RBC

NEXT HEADLINE »California Public Employees Retirement System Has $27.94 Million Stock Position in SoFi Technologies, Inc. $SOFI

Posted by Defense World Staff on Jul 22nd, 2026

California Public Employees Retirement System grew its holdings in Host Hotels & Resorts, Inc. (NASDAQ:HST – Free Report) by 10.5% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 1,496,020 shares of the company’s stock after buying an additional 141,653 shares during the period. California Public Employees Retirement System owned 0.22% of Host Hotels & Resorts worth $28,664,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Zions Bancorporation National Association UT lifted its position in Host Hotels & Resorts by 89.1% during the 4th quarter. Zions Bancorporation National Association UT now owns 1,658 shares of the company’s stock worth $29,000 after acquiring an additional 781 shares during the period. CYBER HORNET ETFs LLC acquired a new stake in shares of Host Hotels & Resorts during the second quarter worth $29,000. SJS Investment Consulting Inc. grew its position in Host Hotels & Resorts by 64.7% in the 1st quarter. SJS Investment Consulting Inc. now owns 1,632 shares of the company’s stock valued at $31,000 after buying an additional 641 shares during the last quarter. MUFG Securities EMEA plc purchased a new position in Host Hotels & Resorts in the 2nd quarter valued at $32,000. Finally, Cedar Mountain Advisors LLC purchased a new position in Host Hotels & Resorts during the 1st quarter worth $35,000. Hedge funds and other institutional investors own 98.52% of the company’s stock.

Host Hotels & Resorts Stock Performance NASDAQ HST opened at $24.44 on Wednesday. The business has a 50 day moving average price of $23.64 and a 200 day moving average price of $20.99. The company has a market capitalization of $16.74 billion, a P/E ratio of 16.63, a PEG ratio of 2.71 and a beta of 1.09. Host Hotels & Resorts, Inc. has a 1-year low of $15.11 and a 1-year high of $25.41. The company has a debt-to-equity ratio of 0.74, a current ratio of 7.91 and a quick ratio of 7.91.

Host Hotels & Resorts (NASDAQ:HST – Get Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.67 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.31. The business had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.59 billion. Host Hotels & Resorts had a return on equity of 15.15% and a net margin of 16.40%.The business’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter last year, the business posted $0.64 earnings per share. Host Hotels & Resorts has set its FY 2026 guidance at 2.100-2.16 EPS. Sell-side analysts expect that Host Hotels & Resorts, Inc. will post 2.14 EPS for the current fiscal year.

Host Hotels & Resorts Dividend Announcement The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, July 15th. Stockholders of record on Tuesday, June 30th were paid a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.3%. The ex-dividend date of this dividend was Tuesday, June 30th. Host Hotels & Resorts’s dividend payout ratio (DPR) is 54.42%.

Wall Street Analysts Forecast Growth Several brokerages have recently weighed in on HST. BMO Capital Markets reaffirmed an “outperform” rating and issued a $27.00 target price on shares of Host Hotels & Resorts in a report on Friday, June 12th. JPMorgan Chase & Co. boosted their target price on Host Hotels & Resorts from $22.00 to $25.00 and gave the stock a “neutral” rating in a research report on Tuesday. Truist Financial increased their target price on Host Hotels & Resorts from $23.00 to $24.00 and gave the stock a “buy” rating in a research note on Tuesday, May 26th. UBS Group raised their price target on Host Hotels & Resorts from $20.00 to $23.00 and gave the company a “neutral” rating in a report on Tuesday, June 2nd. Finally, Raymond James Financial restated an “outperform” rating and issued a $27.00 price target on shares of Host Hotels & Resorts in a research note on Monday, June 8th. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, Host Hotels & Resorts currently has an average rating of “Moderate Buy” and a consensus target price of $24.20.

Check Out Our Latest Stock Analysis on Host Hotels & Resorts

Insider Buying and Selling at Host Hotels & Resorts In related news, EVP Nathan S. Tyrrell sold 58,579 shares of Host Hotels & Resorts stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $22.00, for a total transaction of $1,288,738.00. Following the completion of the transaction, the executive vice president directly owned 697,658 shares in the company, valued at $15,348,476. The trade was a 7.75% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.50% of the stock is currently owned by company insiders.

Host Hotels & Resorts Company Profile (Free Report)

Host Hotels & Resorts, Inc is a real estate investment trust (REIT) focused on owning and managing premium lodging properties. The company’s portfolio predominantly comprises luxury and upper-upscale hotels and resorts operated under leading global brands. Through strategic acquisitions, dispositions and capital investments, Host Hotels & Resorts seeks to enhance long-term value by aligning property-level operating performance with broader market trends in hospitality demand.

The company’s holdings span major urban, resort and conference destinations across North America, Europe and the Asia-Pacific region.

Recommended Stories Five stocks we like better than Host Hotels & Resorts Confidence Is Back, But Earnings Show the Consumer Is Being Picky AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative? 3 Photonics Companies Making Quantum Tech Possible

Receive News & Ratings for Host Hotels & Resorts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Host Hotels & Resorts and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEDorsey Wright & Associates Acquires 16,154 Shares of Broadcom Inc. $AVGO

NEXT HEADLINE »Arvest Bank Trust Division Increases Stake in Caterpillar Inc. $CAT

Posted by Defense World Staff on Jul 22nd, 2026

California Public Employees Retirement System trimmed its position in GoDaddy Inc. (NYSE:GDDY – Free Report) by 5.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 346,712 shares of the technology company’s stock after selling 18,342 shares during the period. California Public Employees Retirement System owned approximately 0.26% of GoDaddy worth $28,663,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Coldstream Capital Management Inc. raised its holdings in GoDaddy by 4.8% in the third quarter. Coldstream Capital Management Inc. now owns 1,887 shares of the technology company’s stock worth $258,000 after purchasing an additional 86 shares during the period. Main Street Financial Solutions LLC grew its holdings in shares of GoDaddy by 1.0% in the 2nd quarter. Main Street Financial Solutions LLC now owns 12,136 shares of the technology company’s stock valued at $2,185,000 after buying an additional 119 shares during the period. Lido Advisors LLC grew its holdings in shares of GoDaddy by 6.2% in the 4th quarter. Lido Advisors LLC now owns 2,083 shares of the technology company’s stock valued at $283,000 after buying an additional 121 shares during the period. Martin Capital Advisors LLP increased its position in shares of GoDaddy by 1.5% in the 4th quarter. Martin Capital Advisors LLP now owns 9,082 shares of the technology company’s stock valued at $1,127,000 after buying an additional 130 shares in the last quarter. Finally, MassMutual Private Wealth & Trust FSB increased its position in shares of GoDaddy by 18.9% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 832 shares of the technology company’s stock valued at $103,000 after buying an additional 132 shares in the last quarter. Institutional investors and hedge funds own 90.28% of the company’s stock.

Insider Transactions at GoDaddy In other GoDaddy news, CAO Phontip Palitwanon sold 542 shares of the business’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $89.86, for a total value of $48,704.12. Following the sale, the chief accounting officer owned 19,995 shares in the company, valued at approximately $1,796,750.70. The trade was a 2.64% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Mark Mccaffrey sold 3,500 shares of the company’s stock in a transaction that occurred on Monday, June 8th. The stock was sold at an average price of $82.92, for a total value of $290,220.00. Following the transaction, the chief financial officer directly owned 105,728 shares of the company’s stock, valued at approximately $8,766,965.76. This trade represents a 3.20% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 16,751 shares of company stock worth $1,480,228 in the last 90 days. 0.93% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth Several research analysts have weighed in on the company. Wells Fargo & Company lifted their target price on GoDaddy from $77.00 to $83.00 and gave the stock an “equal weight” rating in a report on Friday, May 1st. JPMorgan Chase & Co. lowered their price target on GoDaddy from $154.00 to $124.00 and set an “overweight” rating for the company in a report on Thursday, June 18th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of GoDaddy in a research report on Tuesday, June 16th. UBS Group assumed coverage on GoDaddy in a report on Tuesday, May 5th. They set a “neutral” rating and a $100.00 price objective on the stock. Finally, Benchmark decreased their price objective on GoDaddy from $195.00 to $185.00 and set a “buy” rating for the company in a research report on Tuesday, April 28th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and eight have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, GoDaddy presently has a consensus rating of “Moderate Buy” and an average target price of $118.43.

Check Out Our Latest Report on GoDaddy

GoDaddy Price Performance Shares of NYSE GDDY opened at $92.35 on Wednesday. The company has a fifty day moving average price of $85.78 and a 200 day moving average price of $89.91. The firm has a market cap of $12.23 billion, a PE ratio of 14.61, a PEG ratio of 0.86 and a beta of 0.89. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 15.86. GoDaddy Inc. has a 1-year low of $71.59 and a 1-year high of $171.42.

GoDaddy (NYSE:GDDY – Get Free Report) last released its quarterly earnings results on Thursday, April 30th. The technology company reported $1.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.53 by $0.07. The firm had revenue of $1.27 billion for the quarter, compared to the consensus estimate of $1.26 billion. GoDaddy had a return on equity of 366.90% and a net margin of 17.32%.The company’s revenue for the quarter was up 6.1% on a year-over-year basis. During the same quarter last year, the business posted $1.51 EPS. Research analysts predict that GoDaddy Inc. will post 7.15 earnings per share for the current fiscal year.

GoDaddy Company Profile (Free Report)

GoDaddy is a technology company that provides a suite of online services aimed primarily at small businesses, entrepreneurs and individuals looking to establish and grow an online presence. The company’s core activities include domain name registration and aftermarket services, a range of website hosting options, and tools for building, managing and promoting websites. Its product mix is designed to simplify the technical aspects of running a website so customers can focus on their businesses.

Product and service offerings span website builders and managed WordPress hosting, shared and dedicated hosting, e-commerce capabilities, email and productivity solutions, SSL certificates and site security tools, and online marketing and search engine optimization services.

Recommended Stories Five stocks we like better than GoDaddy Confidence Is Back, But Earnings Show the Consumer Is Being Picky AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative? 3 Photonics Companies Making Quantum Tech Possible Want to see what other hedge funds are holding GDDY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GoDaddy Inc. (NYSE:GDDY – Free Report).

Receive News & Ratings for GoDaddy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoDaddy and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINERevolution Medicines, Inc. $RVMD Shares Sold by California Public Employees Retirement System

Posted by Defense World Staff on Jul 22nd, 2026

California Public Employees Retirement System decreased its position in Reinsurance Group of America, Incorporated (NYSE:RGA – Free Report) by 9.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 159,725 shares of the insurance provider’s stock after selling 16,562 shares during the quarter. California Public Employees Retirement System owned 0.24% of Reinsurance Group of America worth $32,609,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also bought and sold shares of RGA. Activest Wealth Management purchased a new position in shares of Reinsurance Group of America during the fourth quarter worth approximately $30,000. Tobam boosted its stake in shares of Reinsurance Group of America by 244.7% in the 4th quarter. Tobam now owns 162 shares of the insurance provider’s stock valued at $33,000 after purchasing an additional 115 shares in the last quarter. International Assets Investment Management LLC bought a new position in shares of Reinsurance Group of America during the 4th quarter valued at $35,000. Entrust Financial LLC bought a new position in shares of Reinsurance Group of America during the 4th quarter valued at $40,000. Finally, Advisory Services Network LLC purchased a new position in Reinsurance Group of America in the 3rd quarter worth $38,000. Hedge funds and other institutional investors own 95.11% of the company’s stock.

Insider Buying and Selling In related news, EVP John W. Hayden sold 414 shares of the firm’s stock in a transaction that occurred on Wednesday, May 20th. The stock was sold at an average price of $214.95, for a total transaction of $88,989.30. Following the completion of the transaction, the executive vice president owned 20,949 shares of the company’s stock, valued at $4,502,987.55. This trade represents a 1.94% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Ronald Herrmann sold 7,000 shares of Reinsurance Group of America stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $210.58, for a total value of $1,474,060.00. Following the transaction, the executive vice president owned 3,938 shares of the company’s stock, valued at $829,264.04. The trade was a 64.00% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.60% of the company’s stock.

Reinsurance Group of America Stock Down 0.8% Shares of NYSE:RGA opened at $238.97 on Wednesday. The company has a debt-to-equity ratio of 0.46, a current ratio of 0.14 and a quick ratio of 0.14. The company has a market cap of $15.65 billion, a PE ratio of 12.95 and a beta of 0.47. The stock’s 50-day moving average is $215.17 and its 200 day moving average is $210.18. Reinsurance Group of America, Incorporated has a 1 year low of $165.52 and a 1 year high of $245.00.

Reinsurance Group of America (NYSE:RGA – Get Free Report) last issued its quarterly earnings data on Thursday, May 7th. The insurance provider reported $6.97 EPS for the quarter, topping the consensus estimate of $6.03 by $0.94. Reinsurance Group of America had a net margin of 4.92% and a return on equity of 13.16%. The business had revenue of $6.49 billion during the quarter, compared to analyst estimates of $6.47 billion. During the same period last year, the business posted $5.66 earnings per share. Reinsurance Group of America’s quarterly revenue was up 23.5% compared to the same quarter last year. Sell-side analysts anticipate that Reinsurance Group of America, Incorporated will post 26.86 EPS for the current year.

Reinsurance Group of America Dividend Announcement The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 2nd. Stockholders of record on Tuesday, May 19th were issued a dividend of $0.93 per share. This represents a $3.72 annualized dividend and a dividend yield of 1.6%. The ex-dividend date was Tuesday, May 19th. Reinsurance Group of America’s dividend payout ratio (DPR) is presently 20.15%.

Analyst Upgrades and Downgrades RGA has been the subject of several recent research reports. UBS Group boosted their price target on shares of Reinsurance Group of America from $220.00 to $236.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 8th. Wells Fargo & Company raised their price objective on Reinsurance Group of America from $261.00 to $269.00 and gave the company an “overweight” rating in a research note on Thursday, July 9th. Evercore reiterated an “outperform” rating and issued a $267.00 price objective on shares of Reinsurance Group of America in a report on Monday, May 18th. Piper Sandler lowered their target price on Reinsurance Group of America from $263.00 to $261.00 and set an “overweight” rating for the company in a research note on Monday, May 11th. Finally, Wall Street Zen upgraded Reinsurance Group of America from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. Seven investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Reinsurance Group of America currently has an average rating of “Moderate Buy” and an average price target of $257.50.

Get Our Latest Stock Analysis on Reinsurance Group of America

Reinsurance Group of America Profile (Free Report)

Reinsurance Group of America, Incorporated (NYSE: RGA) is a leading global provider of life and health reinsurance solutions. Headquartered in St. Louis, Missouri, RGA partners with primary insurance companies to help them manage risk, improve capital efficiency and develop innovative products. The company’s offerings span traditional risk transfer, financial solutions and facultative underwriting services, enabling clients to address a wide range of mortality, longevity, morbidity and critical-illness exposures.

RGA’s product suite includes life reinsurance, living benefits reinsurance, structured reinsurance and financial solutions that support product innovation and capital management.

Recommended Stories Five stocks we like better than Reinsurance Group of America Confidence Is Back, But Earnings Show the Consumer Is Being Picky AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative? 3 Photonics Companies Making Quantum Tech Possible Want to see what other hedge funds are holding RGA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Reinsurance Group of America, Incorporated (NYSE:RGA – Free Report).

Receive News & Ratings for Reinsurance Group of America Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reinsurance Group of America and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAndra AP fonden Grows Position in Moody’s Corporation $MCO

NEXT HEADLINE »California Public Employees Retirement System Decreases Stake in HP Inc. $HPQ

Posted by Defense World Staff on Jul 22nd, 2026

California Public Employees Retirement System lessened its stake in shares of Mid-America Apartment Communities, Inc. (NYSE:MAA – Free Report) by 34.0% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 269,258 shares of the real estate investment trust’s stock after selling 138,697 shares during the period. California Public Employees Retirement System owned 0.23% of Mid-America Apartment Communities worth $32,882,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also modified their holdings of the company. State Street Corp grew its holdings in shares of Mid-America Apartment Communities by 1.6% in the third quarter. State Street Corp now owns 8,119,375 shares of the real estate investment trust’s stock valued at $1,134,520,000 after purchasing an additional 125,130 shares during the period. Norges Bank acquired a new stake in Mid-America Apartment Communities during the fourth quarter worth about $750,603,000. Viking Global Investors LP raised its stake in Mid-America Apartment Communities by 46.7% during the fourth quarter. Viking Global Investors LP now owns 3,880,048 shares of the real estate investment trust’s stock worth $538,977,000 after purchasing an additional 1,234,966 shares during the period. Geode Capital Management LLC raised its stake in Mid-America Apartment Communities by 1.2% during the fourth quarter. Geode Capital Management LLC now owns 3,423,986 shares of the real estate investment trust’s stock worth $473,977,000 after purchasing an additional 40,028 shares during the period. Finally, Invesco Ltd. boosted its holdings in Mid-America Apartment Communities by 6.7% in the 4th quarter. Invesco Ltd. now owns 2,154,600 shares of the real estate investment trust’s stock valued at $299,295,000 after purchasing an additional 134,739 shares during the last quarter. Hedge funds and other institutional investors own 93.60% of the company’s stock.

Mid-America Apartment Communities Stock Performance Shares of Mid-America Apartment Communities stock opened at $132.24 on Wednesday. The stock has a market capitalization of $15.39 billion, a price-to-earnings ratio of 40.07 and a beta of 0.74. The company has a debt-to-equity ratio of 0.99, a current ratio of 0.13 and a quick ratio of 0.13. The business has a 50-day moving average of $134.45 and a 200 day moving average of $131.95. Mid-America Apartment Communities, Inc. has a 12 month low of $120.30 and a 12 month high of $153.93.

Mid-America Apartment Communities (NYSE:MAA – Get Free Report) last issued its quarterly earnings results on Wednesday, April 29th. The real estate investment trust reported $2.13 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.83 by $1.30. Mid-America Apartment Communities had a net margin of 17.60% and a return on equity of 6.61%. The company had revenue of $553.73 million for the quarter, compared to analyst estimates of $555.75 million. During the same period in the prior year, the firm earned $2.20 earnings per share. The business’s revenue for the quarter was up .8% compared to the same quarter last year. Mid-America Apartment Communities has set its Q2 2026 guidance at 2.000-2.120 EPS and its FY 2026 guidance at 8.370-8.690 EPS. As a group, sell-side analysts forecast that Mid-America Apartment Communities, Inc. will post 8.5 earnings per share for the current year.

Mid-America Apartment Communities Announces Dividend The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Wednesday, July 15th will be paid a $1.53 dividend. The ex-dividend date is Wednesday, July 15th. This represents a $6.12 annualized dividend and a dividend yield of 4.6%. Mid-America Apartment Communities’s payout ratio is 185.45%.

Insider Activity In related news, Director Tamara D. Fischer bought 1,100 shares of the firm’s stock in a transaction that occurred on Thursday, May 21st. The stock was purchased at an average cost of $128.55 per share, for a total transaction of $141,405.00. Following the completion of the acquisition, the director owned 1,100 shares in the company, valued at approximately $141,405. This trade represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.60% of the company’s stock.

Analyst Ratings Changes Several analysts have recently weighed in on the stock. Scotiabank increased their price target on shares of Mid-America Apartment Communities from $129.00 to $137.00 and gave the company a “sector underperform” rating in a research note on Thursday, July 9th. Morgan Stanley lifted their price target on shares of Mid-America Apartment Communities from $150.00 to $155.00 and gave the company an “overweight” rating in a research report on Thursday, June 25th. Piper Sandler upped their price objective on Mid-America Apartment Communities from $140.00 to $143.00 and gave the company a “neutral” rating in a report on Tuesday. Truist Financial increased their price objective on Mid-America Apartment Communities from $136.00 to $146.00 and gave the stock a “buy” rating in a research report on Wednesday, June 10th. Finally, Cantor Fitzgerald cut their target price on Mid-America Apartment Communities from $141.00 to $132.00 and set a “neutral” rating for the company in a research note on Monday, May 4th. Eight analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, Mid-America Apartment Communities currently has an average rating of “Hold” and an average price target of $144.75.

Check Out Our Latest Research Report on Mid-America Apartment Communities

About Mid-America Apartment Communities (Free Report)

Mid-America Apartment Communities, Inc (NYSE: MAA) is a publicly traded real estate investment trust (REIT) specializing in the acquisition, development, redevelopment and operation of multifamily residential properties. The company focuses on high-barrier-to-entry apartment communities, offering a mix of one-, two- and three-bedroom homes designed to meet the needs of diverse renter demographics. Its integrated business model encompasses property management, leasing, maintenance and customer service, providing residents with a comprehensive living experience under one ownership platform.

MAA’s portfolio comprises more than 100 communities and over 40,000 apartment homes across key Sun Belt markets.

Further Reading Five stocks we like better than Mid-America Apartment Communities Confidence Is Back, But Earnings Show the Consumer Is Being Picky AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative? 3 Photonics Companies Making Quantum Tech Possible

Receive News & Ratings for Mid-America Apartment Communities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mid-America Apartment Communities and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINECalifornia Public Employees Retirement System Has $29.32 Million Stock Holdings in Coeur Mining, Inc. $CDE